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CHAPTER I
INTRODUCTION AND REVIEW OF RELATED LITERATURE
Research interest has recently developed for a
heterogeneous group of chemical compounds which have potential therapeutic usefulness as antimicrobial agents due to
their capacity to augment responses of lymphocytes and
macrophages.

These compounds have been termed "pro-host"

(40) because, rather than being directly microbicidal,
they enhance the antimicrobial activities of host defense
cells.
Included in such leukocyte-modulating substances
are semi-synthetic or wholly synthetic agents such as
muramyl dipeptide (MOP)
levamisole (33,40).

(13,40), inosiplex (40,111) and

Another such agent is SM-1213 [1,2-0-

isopropylidene-3-0-3'-(N',N'-dimethylamino-n-propyl)-Dglucofuranose, monohydrochloride], a synthetic, substituted
monosaccharide which is reported to potentiate macrophage
bactericidal activity (12,40).

Recent studies describe

antiviral, antitumor and immunomodulatory activities of
SM-1213 (36,74), but few studies have examined for the
effects of SM-1213 on an in vitro fungal infection of host
phagocytes (83,84).

1
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The present work examined for a potential enhancing effect of SM-1213 on the fungistatic or fungicidal
capacities of oil-elicited guinea pig peritoneal exudate
cells (PEC-0) and for the mechanism of such an effect
against both the yeast and the hypha! forms of Candida
albicans, a clinically important dimorphic fungus (44).
Candida albicans is an opportunistic fungus in
that it is commonly found as part of the normal flora of
many mammals, including man.

Diabetes, neoplasms, immuno-

logical defects and immunosuppressive therapy are factors
which favor the pathogenic invasion of Candida and the
development of systemic in~ection (34,105).
tance to infection by

~

Host resis-

albicans involves specific cell-

mediated immune responses (54,55,68), as well as nonspecific host defense mechanisms (47,82,120) in which
phagocytic cells predominate (106).
Cell-mediated immunity (CMI) has been implicated
as being of primary importance (54,55) in protection from
the chronic mucocutaneous form of candidiasis (CMC).

Pos-

itive therapeutic results were obtained after administration of a combination of antifungal antibiotics and injections of transfer factor or immunocompetent lymphocytes,
suggesting a defect in thymus-dependent CMI in these patients (54,55).

Candida! dissemination occurs rarely in

CMC patients, however (58), and the mechanism whereby

3

candidal spread is prevented is not clear.

For example,

in congenitally athymic nude mice (108), resistance to
experimental disseminated candidiasis was greater than
that observed for their phenotypically normal littermates.
Antibody-mediated immune responses were severely impaired
and could not, therefore; account for the enhanced resistance of the athyrnic mice (108).

It was suggested that

high levels of activated macrophages contributed to the
observed effects (108).

This suggestion, along with the

observation that disseminated candidiasis occurs in patients with chronic granulomatous disease (CGD) or myeloperoxidase (MPO) deficiency, where the antimicrobial capacities of phagocytic cells are impaired (60,64), implies
that neutrophils or activated macrophages play the most
important role in host defense against systemic candidiasis (108).

[For reviews, see (30,107).]

It has also

been suggested, however, that phagocytes may actually
promote the establishment of renal candidiasis in thymusbearing mice (58).

Therefore, in order to understand the

critical role macrophages play in host resistance to candidiasis, several researchers have examined the capacity
of mononuclear phagocytes to ingest and kill C. albicans
in vitro (62,118,122).
Conflicting information regarding the ability of
cultured macrophages to destroy

c.

albicans has resulted

4

from the utilization of mononuclear cells derived from
various sites, such as the blood (62), the peritoneum .
(99,118) or alveoli (3,65), and from various animal species
including mouse (118,122), man (62) and rabbit (3,65).
Analysis is further complicated, since resident (118,122),
elicited (99) or activated (65,118) macrophages have been
employed under multiple culture conditions.

Resident or

normal macrophages and circulating blood monocytes are
obtained from untreated animals, while elicited macrophages
are derived from animals injected with an inflammatory
stimulus, such as glycogen, thioglycollate, casein, proteose peptone, mineral oiL, or a bacterial product such
as lipopolysaccharide (LPS).

Activated macrophages are

obtained from animals vaccinated by injection of an agent
such as bacillus Calmette-Guerin (BCG) or infected by
intracellular parasites such as Mycobacterium or Listeria
(48).

During the later states of infection or after host

recovery, activated macrophages possess an enhanced capacity to kill the same or unrelated organisms (72), and
display such characteristics as an increase in size, enhanced spreading, greater numbers of lysosomal granules
and an increase in content of hydrolytic enzymes (17,53).
Elicited macrophages share some, but not all, of these
properties.

[For a review of the biochemical aspects of

mouse peritoneal macrophages in various physiological

5

states as compared to resident macrophages, see Karnovsky
and Lazdins (53).]

The oxidative response of activated.

and elicited macrophages to a phagocytic stimulus is also
enhanced in these cells relative to resident macrophages.
[For a review of the evidence that the phagocytosis-associated oxidative burst is increased in elicited and activated macrophages, see Johnston (48).]
Production of reactive oxygen metabolites by macrophages mediates much of their microbicidal (50,118,127) and
tumoricidal (92,97) activity, although some killing by oxygen-independent mechanisms also occurs (66,67,86).

Oxygen-

dependent systems are classified as such because of a decrease in microbicidal or tumoricidal activity under anaerobic conditions (63,81,97).

However, some microbes (76),

such as Bacteroides fragilis, Staphylococcus epidermidis
and Clostridium perfringens, are normally killed by phagocytes in the absence of air.

Therefore, oxygen-independent

antimicrobial mechanisms must also exist.

Possible media-

tors of macrophage oxygen-independent cytocidal activity
include acid hydrolases (19,117), alkaline phosphatase (29),
lysozyme (11,52,66), a complement cleavage product, C3a
(31), thymidine (121), arginase (24), neutral proteases (1,
2) and cationic proteins (67,101).

Although cytotoxic,

several of these agents may digest dead target cells (56)
killed by predominantly oxidative mechanisms (15,76,118).

6

Particle ingestion by phagocytes is associated with
a metabolic burst characterized by an increase in

oxyge~

consumption, an enhanced oxidation of glucose via the
hexose monophosphate shunt (HMP) pathway, and a substantial
production of hydrogen peroxide (H 2 0 2 ) and superoxide (02)
(48).

The superoxide anion, formed by the addition of an

electron to molecular oxygen, can gain an additional electron to produce H2 0 2 or lose an electron to produce molecular oxygen (4).

Two superoxide radicals can be spontan-

eously dismutated to H2 0 2 and oxygen or enzymatically
converted to these products by the action of superoxide
dismutase (SOD)

(79):
02 + 02 + 2H+

~

H202 + 02

The resulting H2 o 2 can also be removed enzymatically to
produce H2 0 and oxygen by the action of catalase.
The toxicity of 02 and H2 0 2 for microorganisms
was initially proposed by McCord et al (80), since aerobic
organisms contain relatively high levels of SOD and catalase while strict anaerobes lacked these enzymes.

The main

function of these enzymes was hypothesized to protect
microorganisms normally exposed to oxygen from reactive
oxygen metabolites.

This theory was supported by the

finding that not only was superoxide anion capable of
killing organisms, but exposure of

~coli

to high oxygen

tensions induced an increase in microbial SOD levels (38).

7
However, it is not clear that microbial SOD or catalase
can protect microorganisms from damage by external oxyg_en
metabolites (61,118).

While C. albicans contained ten

times the concentration of SOD and catalase as

~

parap-

silosis, both species were killed equally by chemicallygenerated oxygen radicals (118).

c.

Also, Lehrer found that

albicans was killed more easily by reagent H2o2 than

was~

parapsilosis at all concentrations tested (61).

On the other hand, SOD and catalase may be protective
during the interaction of organisms with phagocytic cells.
Neutrophils were reported to kill a low-catalase strain
of~

aureus more easily than a high-catalase strain (77);

catalase-deficient macrophages, whether the deficiency was
genetic or chemically-induced, were better able to kill
Toxoplasma gondii (88).
The production of H202 and 02 by phagocytes may
also lead to the formation of other reactive oxygen species
(4) possessing antimicrobial activity (118).

Such agents

include hydroxyl radical (·OH) and singlet oxygen ( 1 0 2 ),
which may be produced as a result of the interaction of
02 and H20 2 in the following manner:
02 + H20 2

+

10

2 + OH- + •OH

The observed microbicidal activity of phagocyte-produced
H2o 2 and 02 may therefore result from the formation of
other highly reactive oxygen metabolites, as well (56).

8

Of the mononuclear phagocytes of various origin
and physiological state assessed for candida! killing
capacity, resident rabbit alveolar macrophages have been
reported to be candidastatic (103) or candidacidal (65),
while human blood monocytes (62,69) have been shown to be
effectively candidacidal.

Resident mouse (118) or rabbit

(65) peritoneal macrophages have been demonstrated to be
less candidacidal than resident rabbit alveolar macrophages.
Stanley and Hurley reported that resident mouse peritoneal
macrophages could ingest Candida yeast cells, but these
macrophages were eventually destroyed by the intracellular
elongation of hyphal elements (122).

Others have demon-

strated that casein-elicited mouse peritoneal macrophages
suppress the metabolism and growth of phagocytosed yeast
cells for 2-3 hours, but thereafter candida! growth proceeds, resulting in the destruction of the macrophage (99).
In these instances, however, mouse peritoneal macrophages
were maintained in culture for 24-48 hours before infection
which may have resulted in a reduced fungicidal (59) capacity for these cells similar to that observed for other
cultured mononuclear phagocytes.
The ability of resident macrophage populations to
increase their fungicidal efficacy as a result of stimulation is also relevant.

Sasada and Johnston (118) have

reported that LPS-elicited or BeG-activated mouse peritoneal

9

macrophages killed 2-3 times more

c.

albicans cells than

did resident macrophages during a 2-3 hour period.

In the

host, resident macrophages may develop an enhanced capacity
to kill Candida cells via interaction with other cells or
factors (82,85).

For example, the required presence of

lymphocytes for the development of activated macrophages
and the subsequent development of normal cell-mediated
immunity against such intracellular pathogens as Listeria
or Mycobacterium has been demonstrated by Mackaness and
others (72,98).

The lymphokine responsible for the priming

of macrophages for an enhanced oxidative and antimicrobial
response to Toxoplasma gondii has recently been identified
as interferon-y (94).

Maiti

~

al (73) demonstrated that

mouse peritoneal macrophages activated in vivo by BCG or
in vitro by exposure to phytohemagglutinin-induced lymphokines exhibited greater phagocytic and candidacidal activity than resident peritoneal macrophages.

The highest

phagocytic and candidacidal activity, however, was produced
by exposure of macrophages to Candida-induced lymphokines.
Immune mouse serum also enhanced the phagocytic and candidacidal activity of resident, but not activated, macrophages.

Therefore, humoral and cell-mediated mechanisms

may be required for an effective macrophage-mediated control of candida! infection in the host.

10
Immunomodulatory agents such as LPS or MDP apparently act via a lymphokine-independent mechanism of
phage stimulation (48).

ma~ro

These agents can directly prime

cultured mouse macrophages for an enhanced oxidative response (49) in the absence of lymphocytes or lymphokines
(100).

Evidence to support the lymphokine independence of

this mechanism includes:

1) the rapid (16 hour) response

of cultured macrophages to MDP and LPS; 2) the normal
response of macrophages from nude mice lacking mature T
lymphocytes; 3) the defective response of abnormal macrophages not correctable by the addition of normal lymphocytes; and 4) the

responsi~eness

of the macrophage-like

cell line J774.1 to LPS and MDP (100).

MDP has been re-

ported by others to enhance lymphocyte functions (14,123)
as well, but the immediate target cell responsible for
these effects was determined to be the macrophage (32).
Others have also reported that lymphocytes are not required
for LPS induction of tumor cell lysis (28) facilitated by
an enhancement of macrophage oxidative responses (92).
In vivo priming for an enhanced oxidative response
by cultured macrophages has also been achieved by subcutaneous injection of mice with MDP (23).

Similar results

were obtained with nude mice, indicating that in vivo
priming can be accomplished in the absence of mature T
cells.

However, in the immunologically normal animal,

11
activation by this agent might result from a combination
of lymphokine release and a direct effect on the macrophage.
The enhanced oxidative response induced by the
elicitation or activation of macrophages by LPS, BCG, or
MOP in vivo directly correlates to the augmentation of
candida! killing by macrophages in vitro (23,118).

In

addition, administration of MOP prior to or immediately
following infection with

~

albicans prolongs the survival

of intravenously inoculated mice (23).
The reactive oxygen metabolites hydrogen peroxide
CH202), superoxide (02), hydroxyl radical (•OH) and singlet
oxygen ( 1 02) have all been; implicated in macrophage candidacidal activity (118).

Candida parapsilosis, a less

pathogenic species of fungi, elicited a greater oxidative
response and was killed more efficiently by mouse peritoneal macrophages than

was~

albicans (118).

Killing of

both candida! species was inhibited by the exogenous addition of enzymes which remove H202 (catalase) or 02 (superoxide dismutase; SOD) or scavenge ·OH (benzoate) or singlet
oxygen (azide)

(118).

Other data to support the require-

ment of oxygen metabolites in macrophage-mediated candidacidal activity include:

1) the macrophage-like cell line

J774.1 produced less than 10% as much 02 as did resident
mouse peritoneal macrophages and, although candida! ingestion was hormal, candida! killing did not occur (118)

12

and 2) the greater candidacidal activity of LPS-elicited
and BeG-activated macrophages relative to resident mouse
peritoneal macrophages was associated with an enhanced
capacity to release 02 upon exposure to .a membrane-perturbing agent, phorbol myristate acetate (PMA), or phagocytic particles such as opsonized zymosan (49) or Candida
(118).

In addition, reagent H20 2 has been demonstrated

to be effectively candidacidal (118).

The concentration

of reagent H20 2 required for candidacidal activity was
higher than that normally produced by resident or activated
macrophages (92,118).

However, the hydrogen peroxide-

producing capacity of macrophages was measured in the
extracellular environment, where culture medium diluted
its absolute concentration (92,96).

It has been hypo-

thesized that, within the phagocytic vacuole or within
the enclosed interstices which arise as a consequence of
macrophage-to-target cell contact (93) , hydrogen peroxide
levels can reach effectively cytocidal concentrations.
Cytochemical techniques have documented that secretion of
02 and H2o 2 during phagocytosis is greatest at the region
of cell surface contact (10).
An alternative explanation·suggests that macrophageproduced H2o 2 is cytocidal because it is generated at a
low concentration over a prolonged period of time and that
this continued oxidative insult results in target cell

13

destruction (97).

To support this hypothesis, Nathan et al

(97) covalently coupled glucose oxidase to starch particles
to facilitate contact between tumor cells in culture and
the enzyme system.

In the presence of glucose, this system

generated H20 2 at a level equivalent to macrophages and
was 100% tumoricidal.

Evidence supporting the candidacidal

effectiveness of a sustained production of oxygen metabolites arises from experiments in which a cell-free acetaldehyde-xanthine oxidase 02- and H2o 2-generating system
killed Candida and where candida! killing was inhibited
by the exogenous addition of SOD or catalase (118).
Oxygen-dependent mechanisms are important to the
candidacidal activity of the polymorphonuclear leukocyte
(PMN)

(60,63) and monocyte (62), as well as to the macro-

phage, since patients suffering from chronic granulomatous
disease (CGD), a disease in which patients' phagocytes
ingest organisms normally, but are deficient in 02 and
H2o 2 production (27,46), have an impaired ability to kill
Candida.

However, the oxygen-dependent mechanisms utilized

by the PMN and monocyte may differ from that of the macrophage, since, unlike the macrophage, H202-mediated killing
by these cells is enhanced by a myeloperoxidase-H 20 2 halide system (56).

Although peroxidase activity has been

demonstrated histochemically (6) and biochemically (109)
in macrophages, as circulating blood monocytes mature into

14

resident tissue macrophages there is a progressive loss in
peroxidase activity (89).

Although peroxidase activity· in

guinea pig peritoneal macrophages is located in the perinuclear cisternae, the Golgi vesicles and in some membranebound granules (22,25), the functional relevance of this
enzymatic activity in relation to H2 o 2 -mediated killing
mechanisms remains to be established.
The enzyme primarily responsible for the

respira~

tory burst in guinea pig macrophages has recently been
identified as a membrane-bound oxidase that preferentially
uses NADPH as substrate (8).

Evidence supporting a mem-

brane-bound NAD(P)H oxidase as the principle respiratory
burst enzyme includes:

1) the 100,000 x g supernatants

prepared from homogenates of both resting (resident) and
PMA-stimulated macrophages oxidized very low levels of NADH
and NADPH with the subsequent formation of

02;

2) the

100,000 x g pellet prepared from homogenates of resting
cells also oxidized NADH and NADPH with subsequent

02

formation, but activity in homogenates from PMA-stimulated
macrophages was substantially increased and higher with
NADPH than with NADH as substrate; 3) the Km for NADPH was
one-tenth that for NADH, and the maximum velocity of

02

production was twice as great with NADPH as with NADH; 4)
unlike myeloperoxidase (MPO), the oxidase was insensitive
tti azide and cyanide; 5) a direct correlation existed

15
between the degree of intact macrophage respiratory activity and the activity of the oxidase (8).
Of further interest, pre-incubation of oil-elicited
macrophages with immunomodulatory agents such as LPS and
MDP has been reported to result in an enhanced production
of 02 via the activation of the NAD(P)H oxidase of macrophages (51) •

NADPH-dependent 02 production was enhanced in

macrophages pre-treated with LPS or MDP for as little as
15 minutes prior to stimulation with cytochalasin E or
wheat germ agglutinin as compared to macrophages which had
not received LPS or MDP (51).
given that macrophage

Given this information and

cand~dacidal

activity has been di-

rectly correlated to the ability of stimulated macrophages
to produce reactive oxygen metabolites such as H202 and 02
(118), the potential enhancement of macrophage candida!
killing by SM-1213, via the stimulation of macrophage
NAD(P)H oxidase and the subsequent production of H20 2 and
02, was examined and is described in the following report.

CHAPTER II
MATERIALS AND METHODS
A.

Experimental Drugs
SM-1213 [1,2-0-isopropylidene-3-0-3'-(N',N'-di-

methylamino-n-propyl)-D-glucofuranose, monohydrochloride]
was obtained from Greenwich Pharmaceuticals, Inc., Greenwich, CT.

Muramyl dipeptide (MDP, N-acetyl-muramyl-L-

alanyl-D-isoglutamine·~

H2 0, grade A; Calbiochem-Behring

Corp. La Jolla, CA) was used in some experiments in parallel with SM-1213, since both agents are substituted sugar
moieties with immunomodulatory properties (13,35).

The

chemical structures of SM-1213 and MDP are presented in
Figure 1.

Drug solutions were endotoxin-free as determined

by the Limulus amebocyte lysate assay (Sigma Chemical Co.,
St. Louis, MO).
B.

Fungal Strain
Candida albicans, serotype A [a clinical isolate

demonstrating typical carbohydrate assimilation, hyphal
formation in serum and chlamydospore formation on cornmealtween agar (Uni-Yeast Tek system; Corning Medical Microbiology, Roslyn, NY)], was grown aerobically on Sabouraud's
dextrose agar (SDA; Difco, Detroit, MI) for 24 h at 37°C
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Figure 1.

A.

The chemical structure of SM-1213 [1,2-0isopropylidene-3-0-3'-(N',N'-dimethylaminon-propyl)-D-glucofuranose, monohydrochloride]

B.

The chemical structure of muramyl dipeptide
(MDP; N-acetyl-muramyl-L-alanyl-D-isoglutamine)
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prior to use.

Under these conditions, greater than 98% of

the Candida cells were in the yeast phase.
c.

Growth of Candida albicans
When Candida which had been grown on SDA were

inoculated into Sabouraud's dextrose broth (SDB; Difco),
greater than 98% of Candida grew as yeast.

Therefore, to

determine whether SM-1213 had a direct growth inhibitory
effect on the yeast form of Candida, 500 ml side-arm Erlenmeyer flasks containing 100 ml of SDB were inoculated with
1 X 10 5 cfu.

Flasks were incubated aerobically at 37oc on

a rotary shaker.

The increase in absorbance in flasks

with the following concentrations of SM-1213 was monitored
hourly over a period of 10 h:
1000 ng/ml.

0 (control), 1, 10, 100 and

Absorbance readings were taken at 660 nm on a

Spectronic 70 spectrophotometer (Bausch and Lomb, Northbrook, IL).
When Candida which had been grown on SDA were
inoculated into serum-free Waymouth's medium (Flow Laboratories, McLean, VA) supplemented with 2 mg/ml bovine serum
albumin (fraction IV, essentially fatty acid free; Sigma),
5

~g/ml

oleic acid (Sigma) and 50

~g/ml

gentamicin (Scher-

ing Pharmaceutical Corp., PR), greater than 98% of Candida
developed hyphae after 6 h of incubation at 37°C.

Candida

cells displaying elongated germ tubes or pseudohyphae were
defined as "hyphal" in form.

To determine whether SM-1213
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had a direct growth inhibitory effect upon the hyphal form
of Candida, 2SO ml flasks containing SO ml of supplemented
waymouth's medium (SWA medium) with the above concentrations of SM-1213 were inoculated with 1 X 10s cfu and
incubated aerobically for 24 h on a rotary shaker at 37oc.
Since mycelial mass formation prohibited growth analysis
by absorbance measurements, hyphal growth was determined
in each flask by dry weight analysis after Millipore filtration of the cultures.

Three washes of the Candida were

performed with distilled water during each filtration
(0.4S

~m

pore size), followed by oven drying of the filters

at 60°C for 48 h.
D.

Leukocyte Harvest
One male guinea pig (Hartley strain, 7SO g) was

used in each of the experiments as a source of peritoneal
exudate cells (PEC).

To obtain oil-elicited peritoneal

exudate cells (PEC-0), 20 ml of paraffin oil (light, white
mineral oil; Fisher Scientific Co., Chicago, IL) was injected into the peritoneal cavity 72 h prior to animal
sacrifice.

PEC-0 were harvested from the peritoneum by

five serial washes of 20 ml volumes of ice-cold Eagle's
basal medium (Flow) containing SO

~g

gentamicin/ml (Scher-

ing) and S units sodium heparin/ml (Upjohn, Kalamazoo, MI).
The washes were delivered into sterile polystyrene tubes
and the cells were pelleted by centrifugation at 2SO x g
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for 5 min at 2ooc in an International PR-6 centrifuge
(International Equipment Co., Needham Heights, MA).

The

cells were washed by centrifugation in phosphate buffered
saline (PBS, pH 7.3, % w/v in distilled water:

NaCl 0.8,

KCl 0.02, KH2P04 0.012 and Na 2 HP0 4 0.091), quantified in
a hemacytometer, and diluted to the appropriate concentration in SWA medium.

Differential counts of at least

200 PEC-0 were performed on Wright-Giemsa stained smears.
The average cellular profile derived from multiple experiments was as follows:

77.2 ± 0.8% macrophages and mono-

cytes, 2.6% PMN and 20.2% lymphocytes, mast cells and
eosinophils.

Total cellular harvest per animal averaged

1.17 (±0.14) X 108 PEC-0.
To obtain resident peritoneal exudate cells (PEC-r),
harvesting procedures were identical to those described
above; however, no oil or other inducing agent was used.
The average cellular profile for resident PEC was as follows:

93.0 ± 3.3% macrophages and monocytes, 0% PMN and

7.0% lymphocytes, mast cells and eosinophils.

Total cellu-

lar harvest per animal averaged 3.07 (±0.61) X 10 7 PEC-r.
After 2 h in culture, greater than 95% of resident or oilelicited adherent cells consisted of macrophages, as determined by Wright-Giemsa stain.
E.

Cell Culture
PEC (>97% viable by trypan blue dye exclusion)
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were seeded onto 60 mm diameter plastic petri plates (tissue culture grade; Becton Dickinson Co., Oxnard, CA)

t~

a

final concentration of 2 to 5 X 106 cells per plate in a
total incubation volume of 3 rnl.

In some studies, 16 mm

diameter wells (24-well, rnultiwell tissue culture plates;
Becton Dickinson) were plated with 1 to 2.5 X 106 PEC per
well in a total incubation volume of 2 rnl.

To allow attach-

ment of PEC to the plates, cells were incubated in SWA
medium with or without SM-1213 for 2 h at 37°c in 95% airS% C02.

After 2 h, non-adherent cells were removed by

washing once with SWA medium and appropriate medium (with
or without SM-1213) was replaced for those samples requiring further incubation.

Final concentrations of SM-1213

in the incubation medium were:

0 (control), 0.1, 1, 10,

and 100 ng/rnl.
In experiments examining Candida-infected PEC,
cell culture procedures were as described above except
that yeast cell suspensions were inoculated into the culture medium directly following the addition of peritoneal
cells in a Candida-to-PEe ratio of 1:5 to 1:10.
F.

Candida! Hyphal Elongation
PEC were delivered into plastic petri plates (60

mrn) containing two 2.2 ern square glass cover slips and were
inoculated with Candida yeast cells as described above.
intervals of 2, 4 or 6 h, a cover slip with adherent,

At
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infected PEC was removed from each of duplicate culture
dishes, fixed in 95% methanol for 5 min, and inverted onto
a microscope slide.

The infected peritoneal cells were

examined by phase contrast microscopy at lOOOX for intracellular hyphal formation and elongation, since viable
yeast cells converted to the hyphal form intracellularly.
The hyphal lengths of Candida contained in 50 to 200 peritoneal cells were determined by a microscope eyepiece
micrometer.
G.

Candida! Viability
Hyphal viability was quantitatively determined by

the microcolony method

(45~.

of the dimorphic nature of

c.

This method took advantage
albicans, which grew exclu-

sively (>98%) in the yeast form when incubated aerobically
on SDA.

Briefly, a cover slip was removed from each of

duplicate culture dishes and rinsed in successive baths of
PBS and SOB.

Washed cover slips were drained by touching

the cover slip to filter paper.

The cover slips were in-

verted onto SDA (3 mm thick) and incubated aerobically at
30°C.

Similar results were obtained if PEC were first

lysed with a solution of 0.5% Non-idet detergent (Sigma)
before placement of the cover slips on agar.

The cultures

were examined by phase contrast microscopy for Candida
microcolony formation.

Each Candida which produced at

least one microcolony of four adjacent yeast cells was
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defined as viable.

The percentage of non-viable Candida

was determined by counting 100 to 200 Candida-containing
peritoneal cells:
%

Candida
killed

Number of Candida unable
to form m1crocolonies

= ~N:-u-rnb-;--e-r-o~frc=-a.;;..n.;;..d~1~d;;;;a;.;;;.;::...;;..:;N:-;urnb~:;.;e;.;.r;;;..;;;;.o~f~C:-a-n"""dM1,...,d=--a
able to form
microcolonies

+

X 10 0

unable to form
microcolonies

Additional experiments were conducted to determine
the effect of SM-1213 pre-treatment of PEC on their capacity
to inhibit intracellular hyphal elongation and to reduce
candidal viability subsequent to the removal of the drug.
PEC were pre-incubated with drug for 2, 4, or 6 h and washed
3X in SWA medium to removeiresidual drug prior to inoculation with yeast cells.

Hyphal elongation was determined

microscopically by eyepiece micrometer and candidal viability was assessed by the microcolony technique previously
described 2 h after infection of PEC.
In some experiments, both the microcolony technique
and the methylene blue dye exclusion technique of Lehrer
and Cline (63) were used for determining candidal viability.
H.

Enzyme Assays and Protein Determination
Culture fluid and non-adherent cells were removed

from culture dishes at 2 h and again at 4 or 6 h for samples incubated for 4 or 6 h, respectively.

Values obtained

at 2 h were combined with those obtained at 4 or 6 h to
represent total non-adherent PEC or culture fluid values
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over the 4 or 6 h incubation period.
Non-adherent PEC and extracellular Candida, if
present, were separated from the culture fluid by centrifugation at 500 X g, 4°C for 10 min.

The pellet was treated

with 3 ml 1% Triton X-100 detergent (TX-100; Sigma) for 10
min to disrupt non-adherent PEC or, in Candida-infected
samples, with 0.5% Non-idet detergent (NI; Sigma). NI was
used on infected samples since, at this concentration
(0.5%), it disrupted PEC without affecting the viability
of Candida cells.

Following disruption of non-adherent

PEC, cellular debris and Candida cells, if present, were
removed by centrifugation at 1000 x g, 40 C for 10 min.
c

At 2, 4, or 6 h, ddherent PEC were treated with
3 ml of 1% TX-100 or 0.5% NI for 10 min to disrupt the
attached cells.

A rubber policeman was used to facilitate

the removal of cells from culture dishes.

Cellular debris

and Candida cells, if present, were pelleted by centrifugation at 1000 x g, 4o C for 10 min.
Culture fluid and supernatants from adherent and
non-adherent cell lysates were either stored frozen at
-40°C until assayed or, since freezing and thawing resulted
in a decrease in catalase activity, samples to be assayed
for this enzyme were assessed immediately after centrifugation. Enzyme activities for adherent and non-adherent PEC
fractions were expressed in units per mg adherent cell or
non-adherent cell protein, respectively. Enzyme activities
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for culture fluid fractions were expressed in units per mg
total cell protein.

Enzyme assays and protein determina-

tions were performed as follows:
1.

Catalase (EC 1.11.1.6)
Catalase activity was determined by the method of

Beers and Sizer (7) in which the disappearance of reagent
hydrogen peroxide (Mallinckrodt, Inc., Paris, KY) was
followed spectrophotometrically at 240 nm.

The decrease

in absorbance was measured with a Gilford 2400 recording
spectrophotometer for a period of 3 min at 25°c.

Each

cuvette contained 1.9 ml glass distilled H2 0 and 1.0 ml
0.059 M H2 0 2 in 0.05 M KH 2 Po 4 buffer (pH 7.0) to which 0.1
ml of the biological sample was added.

Catalase activity

in units was calculated using bovine liver catalase (thymol
free, 17,000 U/mg protein; Sigma) as standard.

One unit

decomposed 1 pmole H2 o 2 per min at 25oc, pH 7.0, as determined from absorbance measurements at 240 nm using a molar
extinction coefficient of 70 M- 1 cm- 1 for H2 o 2 (7).
2.

Peroxidase (EC 1.11.1.7)
Peroxidase activity was measured as the decrease

in sample fluorescence following the oxidation of scopoletin (7-hydroxy-6-methoxy coumarin; Sigma) by peroxidase
and H2 o 2 (114).

Fluorescence was monitored for a period

of 5 min on an Aminco-Bowman spectrophotofluorometer (American Instrument Co., Silver Springs, MD) with an excitation
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wavelength of 350 nm and an emission wavelength of 460 nm.
Each cuvette contained 2.2 ml 0.05 M KH 2P0 4 buffer (pH ·7.0),
0.1 ml 0.1 M H202 and 0.1 ml 0.2 mM scopoletin in phosphate
buffer, to which 0.1 ml of the biological sample was added.
Peroxidase activity was quantitated from a standard curve
using horseradish peroxidase (HPO, type I, salt free powder,
105 U/mg solid; Sigma) as standard.

One unit of HPO oxi-

dized 1 ~mole of o-dianisidine per min at 25°c, pH 5.0, as
determined from absorbance measurements at 460 nm using a
molar extinction coefficient of 1.13 X 10 4 M-lcm-1 (20).
3.

S-N-acetylglucosaminidase (EC 3.2.1.30)
The method of Woollen ~ al (129) was used to

measure S-N-acetylglucosaminidase (NAGA) activity in biological samples.

The formation of p-nitrophenol from p-

nitrophenyl-N-acetyl-S-D-glucosaminide (Sigma) was determined spectrophotometrically at 400 nm.

Borosilicate glass

test tubes (16 X 125 mm), on ice, received 0.5 ml 0.1 M
sodium citrate buffer (pH 5.0), 0.1 ml 3 mM p-nitrophenylN-acetyl-S-D-glucosaminide in citrate buffer, and 0.5 ml of
the biological sample and were incubated for 2 h at 37°C in
a shaking water bath.

Following incubation, the tubes were

placed on ice, the reaction was stopped by the addition of
3.0 ml 0.2 M sodium borate buffer (pH 9.8) to each tube,
and the absorbance at 400 nm was read.

Enzyme activity was

quantified in units using jack bean NAGA (Sigma) as stand-
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ard.

One unit hydrolyzed 1.0

~mole

of p-nitrophenyl-N-

acetyl-S-D-glucosarninide to p-nitrophenol and

N-acetyl~

glucosamine per min at 25oc, pH 8.0, as determined from
absorbance measurements at 400 nm using a molar extinction
coefficient of 1.67 X 104 M-lcm-1
4.

(41).

Lactate dehydrogenase (EC 1.1.1.27)
Lactate dehydrogenase (LDH) activity was determined

by the method of Wacker

~

al (125) utilizing the principle

that LDH catalyzes the conversion of L-lactate to pyruvate
with the simultaneous reduction of a molar equivalent of
nicotinamide adenine dinucleotide (NAD); the production of
reduced NAD (NADH) , then,

~s

measured by the increase in

absorbance at 340 nm, is proportional to the activity of
LDH.

Therefore, 3 ml of the following reaction mixture

(Super Stat Pack; Calbiochem, La Jolla, CA) were delivered
into each cuvette, followed by 0.1 ml of biological sample:
3.5 mM NAD, 0.05 M glycine buffer (pH 8.8), and 70 rnM lactate.

All components were pre-warmed in a water bath to

the assay temperature of 3ooc.

LDH activity in units was

calculated using rabbit muscle LDH (substantially free of
pyruvate kinase, 900 U/mg protein; Sigma) as standard.
unit oxidized 1.0

~mole

One

of lactate to pyruvate per min at

30°C, pH 8.8, as determined from absorbance measurements at
340 nm using a molar extinction coefficient of 6.22 X 10 3
M- 1 cm- 1 (131).
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5.

Protein Determination
Protein determinations on cell lysate supernatants

were conducted according to the method of Lowry

~

al (71)

using bovine serum albumin (fraction IV, essentially fatty
acid free; Sigma) as standard.
pared as follows:

Working reagents were pre-

Reagent A consisted of 1.0 ml 2% w/v

potassium-sodium tartrate in H20, 1.0 ml 1% w/v copper
sulfate in H20, and 98.0 ml 2% w/v sodium carbonate in
0.1 N NaOH; Reagent B consisted of 2 N Folin-Ciocalteu
Phenol Reagent (Sigma) diluted 1:1 v/v with H2 0.

Bio-

logical sample (0.1 ml) was diluted with 0.4 ml H20 and
allowed to react for 10 min at 25°C with 2.5 ml of Reagent
A.

Reagent B (0.25 ml) was added and allowed to react for

30 min at 25°C.

Test tubes containing the reaction mixture

were centrifuged for 5 min at 1000 x g and the absorbance
of the supernatant at 750 nm was determined.
I.

Determination of Hydrogen Peroxide and Superoxide Anion
Generation
Hydrogen peroxide generation was quantitated by the

method of Pick and Keisari (104) based on the H2 02-mediated,
HPO-dependent oxidation of phenol red.

Oxidized phenol red

was measured by its absorbance at 610 nm.

PEC were plated

onto 16 mm culture dishes and incubated for 2 or 6 h in SWA
medium to which SM-1213 or MDP was added.

Dishes were

washed once with SWA medium at 2 h to remove non-adherent
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cells.

After incubation, adherent cells were washed 3X

with phenol red-free Earle's balanced salt solution (EBSS;
Flow) and covered with 2 ml per dish of pre-warmed phenol
red solution (PRS).

PRS was prepared immediately prior to

use by dissolving 0.1 mg phenol red/ml (phenolsulfonphthalein, sodium salt; Sigma) and 8.5 U HPO/ml (type I, 105
units/mg solid; Sigma) in EBSS.

Opsonized zymosan was

added to a final concentration of 1 mg/ml and the dishes
were incubated at 37°C.

Plates which did not receive op-

sonized zymosan were assessed for phenol red oxidation and
values were subtracted from those of test samples as background oxidation.

After 30 min, the culture fluid was

transferred to tubes which were centrifuged for 5 min at
1000 x g.
of 10

~1

Supernatants were made alkaline by the addition
of 1 N NaOH per tube and the extracellular genera-

tion of H20 2 was determined by the absorbance at 610 nm.
PEC adherent to the culture dishes were disrupted with 0.5
ml 1% TX-100, scraped with a pipette tip to dislodge cells,
and incubated for 30 min at 37°C with 2 ml PRS.

The H20 2

generation by the cell lysate was determined spectrophotometrically after centrifugation and alkalinization of the
supernatants as described above.

Hydrogen peroxide con-

centration was determined using a standard curve which
utilized PRS and a range of H202 concentrations up to
200

~M.
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Superoxide anion generation was measured by one of
two methods.

Whole cell 02 generation was determined by a

modification of the quantitative nitroblue tetrazolium salt
(NBT) reduction test described by

Weiss~

al (126).

The

major modification involved using oil-elicited guinea pig
PEC adherent to culture dishes rather than human peripheral
blood monocytes and neutrophils in suspension.

After incu-

bation for 2 or 6 h in SWA medium to which SM-1213 was
added, adherent cells in 60 mm dishes were washed 3X with
PBS and covered with the NBT reaction mixture.

The reac-

tion mixture contained 0.4 ml Hank's balanced salt solution
without phenol red (HBSS; Flow), 0.4 ml 0.2% NBT in 0.85%
saline, 0.1 ml 0.01 M KCN, and 0.1 ml opsonized zymosan or
Candida.

NBT reduction was allowed to proceed at 37°C,

95% air-5% C0 2 atm for 15 min after which time the reaction
was stopped by the addition of 10 ml of cold 0.5 N HCl.
PEC were harvested from the plates with a rubber policeman,
the suspension was centrifuged in test tubes at 1000 x g
for 20 min, and the reduced dye was extracted from the
pellet with 4 ml pyridine in a boiling water bath.

The

centrifugation was repeated and the supernatant absorbance
was read at 515 nm.

In some studies, cell-associated and

extracellular NBT reduction were determined separately on
the cell pellet and supernatant fractions, respectively.
The concentration of NBT reduced was calculated
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from a standard curve constructed by reducing known quantities of NBT with a xanthine-xanthine oxidase system •.
This system reduced 11.4 nmoles NBT per min at 37°C, pH
7.0, as calculated from absorbance measurements at 515 nm
using a molar extinction coefficient of 2.8 X 103 M-1cm-1
(126) for NBT and contained 0.4 ml of varying concentrations of NBT in 0.85% saline, 1.8 ml of 2.22 X 10-4M xanthine (Calbiochem), and 1.8 ml of 2.22 X lo-aM xanthine
oxidase (grade III, from buttermilk, 1.3 U/mg protein;
Sigma) in 0.05 KH 2 Po 4 buffer (pH 7.0) containing 1 X 10- 4M
EDTA (Sigma).

Xanthine oxidase (EC 1.2.3.2) concentration

was quantitated from absorbance measurements at 450 nm
using a molar extinction coefficient of 7 X 104 M-1cm-1
( 78) •
In some experiments, whole cell 02 generation was
measured spectrophotometrically by the reduction of terricytochrome c (49).

After incubation for 2 or 6 h in SWA

medium to which SM-1213 was added, adherent cells in 60 mm
culture dishes were washed 3X with PBS and covered with
3 ml of an 80

~M

solution of ferricytochrome c (FCC; type

III; Sigma) in phenol red-free HBSS.

Opsonized zymosan

was added to the culture dishes which were incubated for
90 min at 37°C in 95% air-5% C0 2 •

After incubation, cul-

ture fluid was transferred to tubes on ice, centrifuged
for 5 min at 1000 x g, and the absorbance of the super-
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natants at SSO nm was read.

The concentration of ferri-

cytochrome c reduced was calculated using the molar extinction coefficient of 2.1 X 104 M-lcm-1 (49).
Ferricytochrome c or NBT reduction was used to
quantitate NADPH-dependent (SO,Sl) superoxide anion generation by cell-free PEC lysates.

PEC were incubated in 16

mm dishes for 2, 4 or 6 h either in SWA medium containing
SM-1213 or in SWA medium alone.

After incubation, adherent

cells were washed 3X with PBS and covered with the stimulant mixture:

1.6 ml phenol red-free HBSS, 0.2 ml 0.01 M

KCN, and 0.2 ml opsonized zymosan.

Samples were incubated

at 37oc in 9S% air-S% co 2 to allow phagocytosis of zymosan
particles.

After lS min, adherent cells were washed once

with PBS, lysed by exposure to O.S ml 1% TX-100 for 10 min,
and dislodged from the plates by scraping with a pipette
tip.

Cell lysates were incubated with the following reac-

tion mixture for lS min at 37°C in 9S% air-S% C0 2 :

l.S ml

phenol red-free HBSS, 0.2 ml 0.01 M KCN, 0.1 ml 0.2 M
NADPH (Sigma), and 0.2 ml 0.8 mM ferricytochrome c or 0.2
ml 0.4% NBT in HBSS.

In addition, cell lysates from sam-

ples initially incubated in SWA medium alone and not previously exposed to SM-1213 received drug in the above
reaction mixture in order to determine the possible direct
effect of SM-1213 on NADPH-dependent superoxide generation
by cell lysates.

Ferricytochrome c or NBT reduction in
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supernatants was measured spectrophotometrically by absorbance at 550 or 515 nm, respectively, after transfer· of
samples to test tubes on ice and centrifugation for 5 min
at 1000 x g.
In order to determine the percentage of NBT or
ferricytochrome c reduction mediated by 02, some samples
were incubated in the presence of superoxide dismutase
(SOD, from bovine blood, EC 1.15.1.1, 2800 U/mg protein;
Sigma) at a final concentration of 3000 U/ml.

Average SOD-

inhibitable reduction, compiled from multiple experiments,
constituted 72.7 ± 14.4% of total detectable reduction.
SOD which had been heated for 10 min in a boiling water
bath or autoclaved for 15 min, catalase (bovine liver catalase; Sigma) at a final concentration of 1700 U/ml, or
bovine serum albumin (BSA; Sigma) was included in some
samples measured for 02 or H2 0 2 generation, as indicated
in the Results section.
Opsonized zymosan or c. albicans was prepared by
incubating 100 mg of zymosan (zymosan A from

s.

cerevisiae

yeast; Sigma) or 1 X 108 Candida yeast cells with 6 ml of
whole, normal guinea pig serum for 20 min at 37oc in a
shaking water bath.

The particles were washed by centri-

fugation in PBS for 5 min at 250 x g and resuspended to
50 mg zymosan/ml or 1 X 10 7 Candida/mi.

Culture dishes

received a final concentration of 0.5 to 1 mg opsonized
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zymosan/ml or 0.5 to 1 X 10 6 opsonized yeast cells/plate.
Opsonization of particles was indicated by direct agglutination testing using rabbit anti-guinea pig immunoglobulins
(Accurate Chemicals, Westbury, NY).
J.

Determination of the Candidacidal Activity of the
NADPH-NAD(P)H Oxidase System
The effect of SM-1213 on the candidacidal activity

of a cell homogenate-derived NAD(P)H oxidase 02-generating
system was determined.

After incubation in SWA medium for

2 or 6 h, adherent cells (2.5 X 10 6 PEC) in 16 mm culture
dishes were washed once with PBS, covered with the follow,•

ing stimulant mixture, and 1 incubated at 370c in 95% air5% C0 2 :

1.6 ml phenol red-free EBSS, 0.2 ml 0.01 M KCN,

and 0.2 ml opsonized zymosan.

After 15 min, adherent cells

were washed once with PBS, covered with 1.5 ml EBSS, and
scraped with a pipette tip to disrupt and dislodge cells.
Some samples received SOD at a final concentration of
3000 U/ml.

Cell homogenates were transferred to glass

test tubes (16 X 125 mm) containing:

D.l ml SM-1213, 0.2

ml 0.01 M KCN, 0.1 ml 0.2 M NADPH, and 0.1 ml (8 X 105)
Candida yeast cells in EBSS.

Some cell homogenates were

heated in a boiling water bath for 10 min and cooled to
370C before addition to the above reaction mixture.

After

90 min at 37oc in a shaking water bath, samples were serially diluted and plated in duplicate by the spread plate
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method on SDA.

Candida! viability was assessed by colony

enumeration after plates were incubated aerobically at ~7°C
for 48 h.

Alternatively, candida! viability was determined

by methylene blue dye exclusion (63).

Similar results were

obtained if PEC were lysed with 0.5% NI rather than disrupted by physical means.
To determine the candidacidal activity of cell
homogenates not dependent upon NAD(P)H oxidase, some samples did not receive substrate NADPH in the reaction mixture.

In samples receiving SOD, the candidacidal activity

of the NADPH-NAD(P)H oxidase system was inhibited an average of 62.5 ± 2.89% over
K.

t~ree

experiments.

Statistical Analysis
For candida! killing percentages, the Chi-square

(x2)

analysis or the Student's t test was used; for all

other averages, the Student's t test was utilized.

Aver-

ages were represented plus or minus (±) the standard error
of the mean.
p < 0.05.

Values were considered significant when

CHAPTER III
RESULTS
A.

Direct Effect of SM-1213 on the Growth of

c.

albicans

SM-1213 had no direct fungicidal or fungistatic
activity against the yeast or hyphal form of Candida at
any drug concentration tested over a 10 h (yeast) or 24 h
(hyphae) incubation period (Table I) •
B.

Effect of SM-1213 on Hyphal Elongation of Phagocytosed

c.

albicans
Since the development of hyphal elements has been

implicated in the pathogen~sis of candida! disease (128),
intracellular hyphal formation and elongation by phagocytosed yeast cells was measured.

In SWA medium alone,

100%.of Candida cells developed hyphae during the 6 h
incubation period.

All of the yeast cells phagocytosed

by untreated PEC-0 initiated hyphal formation, while PEC-0
incubated in the presence of SM-1213 (1 ng/ml) reduced the
percentage of hyphae formed to 92% (P < 0.05).

In addition,

of those yeast cells which initiated hyphal formation, the
average hyphal length attained after 6 h of incubation was
shorter in drug-treated than in untreated (control) PEC-0
(Figure 2).

This effect was most pronounced at the 1 ng/ml
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Table I.

The effect of SM-1213 on in vitro growth of
yeast and hypha! forms ofiC. albicans

SM-1213
concentration
(ng/ml)

Candida! growth (% of control)
Yeast

form~

Hypha! formb

0

100

100

1

101

105

10

101

105

100

100

103

1000

101

98

a) Yeast cell growth was monitored as the increase in
absorbance of candida! cultures in SDB. Data shown
are relative absorbance of control and drug-treated
samples after 10 h of growth at 370C and are representative of the absence of drug effect at earlier
intervals.
b) Hypha! growth was determined by dry weight analysis
of candida! cultures as described in Methods section.
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Figure 2. Elongation of c. albicans hyphae
within control and drug-treated PEC-0. PEC-0 were
infected with c. albicans yeast cells in vitro and
incubated in the presence of various concentrations
of SM-1213 for the designated time intervals. Hyphal
elongation of phagocytosed yeast cells was significantly reduced by SM-1213 treatment of PEC-0 for 6 h,
as indicated at right by an asterisk (*). Data represent means ± SEM derived from three experiments.
Final drug concentration in incubation medium:
(e),
0 ng/ml; <+> , 0.1 ng/ml; <•> , 1. 0 ng/ml; (.&) , 10.0
ng/ml.
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drug level, a drug concentration at which no direct anticandida! effects were observed in the absence of PEC {Table
I).

No significant drug-induced differences in hyphal

length were observed at any drug concentration tested after
incubation for 2 or 4 h {Figure 2).
Although hyphal formation was initiated intracellularly, the majority of viable hyphae within control
and drug-treated PEC-0 appeared to penetrate the phagocyte
cell membrane by 6 h, growing into the extracellular medium.
In these instances, then, inhibition of hyphal elongation
was not solely "intracellular" although the mechanisms of
growth inhibition may have ;·been initiated while hyphae were
wholly within PEC.

c.

Effect of SM-1213 on the Killing of Phagocytosed

c.

albicans
Although essentially all of the

~

albicans yeast

cells phagocytosed by PEC-0 could initiate hyphal formation, some hyphae were eventually killed by the microbicidal action of the phagocytic cells.

As shown in Table

II, after incubation with Candida for 6 h, untreated PEC-0
{0 ng/ml) killed 22% of intracellular Candida while PEC-0
incubated with Candida and either 0.1 or 1.0 ng SM-1213/ml
for 6 h killed 35.5 or 46% of the intracellular fungus,
respectively.

At the 10 ng/ml drug level, SM-1213 did not

induce PEC to kill a significantly greater percentage of
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Table II.

The effect of SM-1213 on the viability of
phagocytosed Candida albicans

% Candida killed

SM-1213
concentration
(ng/ml)

PEC-0 incubated
with druga

PEC-0 pre-incubated
with drugb

Medium control£

2.5 ± o.5d

2.5 ± 0.5

0

22.0 ± 5.6
2.5*~

0.1

35.5 ±

1.0

46.0 ± 9.6*

10.0

25.0 ±

~.0

16.5 ± 2.5
36.5 ± 2.5*
30.0 ± 1.0*
34.0 ± 1.0*

a) PEC-0 were infected and incubated with drug for 6 h.
The percent intracellular Candida killed was determined by the microcolony techn~que as described in
Methods section.
b) Non-infected PEC-0 were pre-incubated with drug for
6 h, washed, inoculated with Candida yeast cells and
incubated for 2 h in the absence of drug. Percent
intracellular Candida killed was determined as described in a) above.
c) Candida! viability was determined in PEC-free samples
by the methylene blue dye exclusion technique (63).
d) Mean ± SEM
e) An asterisk (*) denotes P < 0.05 between untreated
PEC (0 ng/ml) and drug-treated PEC samples.
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intracellular Candida than controls.

However, the initi-

ation of fungal injury was suggested by a reduction in
average hyphal length observed for this group (Figure 2),
although growth inhibition was not statistically significant.
D.

Effect of SM-1213 Pre-incubation of PEC-0 on Hyphal
Elongation of Phagocytosed

c.

albicans

The results presented thus far suggest that SM-1213
could potentiate one or more intracellular candidacidal
processes expressed by PEC-0.

If such potentiation oc-

curred via the modulation of the PEC-0 themselves and not
via a direct effect on Canqida cells, then pre-incubation
of PEC-0 with SM-1213 and removal of drug prior to infection with Candida should result in enhanced candidal killing by drug-treated, relative to untreated, PEC-0.

To

test this hypothesis, PEC-0 were pre-incubated with SM-1213
for 6 h and adherent cells were washed to remove residual
drug.

Monolayers were infected with yeast phase Candida

cells, incubated for 2 h in the absence of drug, and assessed for intracellular hyphal growth.

Significant in-

hibition of intracellular hyphal elongation occurred during
the 2 h incubation in PEC-0 pre-incubated with drug, at all
concentrations tested, relative to PEC-0 pre-incubated in
the absence of drug (Figure 3).

No significant drug-
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Figure 3. Hyphal length of phagocytosed c.
albicans within pre-incubated control and drug-treated
PEC-0. PEC-0 were pre-incubated for 6 h in the presence or absence of drug. PEC-0 monolayers were washed,
infected with yeast cells, incubated for 2 h in the
absence of drug and assessed for intracellular hyphal
growth. Each bar represents the mean ± SEM for 200
intracellular hyphae. Hyphal length was significantly
reduced in PEC-0 pre-incubated with SM-1213, as indicated at right by an asterisk (*).
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induced retardation of hypha! growth occurred when PEC-0
were pre-incubated with drug for less than 6 h prior to·
candida! infection (data not shown) •
E.

Effect of SM-1213 Pre-incubation of PEC-0 on the Killing of Phagocytosed C. albicans
PEC-0 were pre-incubated in culture for 6 h in the

presence or absence of drug.

Adherent PEC-0 were washed,

infected with yeast cells, incubated for 2 h in the absence
of drug, and assessed for candida! killing.

PEC-0 pre-

incubated in the absence of drug killed 16.5% of intracellular Candida during the subsequent 2 h infection period.
In comparison, PEC-0 pre-incubated with 0.1 to 10 ng/ml
SM-1213 for.6 h killed a significantly greater percentage
of intracellular Candida (30-36.5%) than controls (0 ng/ml)
during the 2 h infection period when drug was no longer
present (P

<

0.02, Table II).

In all but the 10 ng/ml

treatment group, pre-incubated PEC-0 killed an equal or
somewhat lower percentage of intracellular Candida than
did PEC-0 incubated with drug from the time of infection
(Table II).

However, killing of Candida within pre-incu-

bated PEC-0 was substantial, since Candida were exposed to
PEC-0 for only a 2 h infection period relative to a 6 h
infection period for PEC-0 incubated simultaneously with
Candida and drug.
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F.

Effect of SM-1213 on PEC Enzyme Activities and Protein
Content
Since the work of Sasada and Johnston (118) and of

Lehrer and Cline (64) emphasized the contribution made by
active oxygen species such as H2 0 2 and 02 to candidacidal
systems of phagocytes, an examination of killing mechanisms
involving these agents was undertaken.

It was decided to

focus first on possible drug-mediated effects on the efficacy, utilization and catabolism of H2 o2 •

This might

result, for example, from a drug-induced modification of
the activity of peroxidase, an enzyme associated with an
H2 0 2 -mediated microbicidal: system of phagocytes (62,64,102),
or catalase, an enzyme associated with the abrogation of
candidacidal activity of macrophages in culture (118).
PEC were incubated with SM-1213 for 6 h and adherent cell populations from resident (90-95% peroxidase
positive), oil-elicited (45-50% peroxidase positive) and
oil-elicited Candida-infected PEC were examined for enzyme
activity (Table III).

After 6 h of incubation with either

0.1 or 1.0 ng SM-1213/ml, significant drug-induced reductions in catalase activity occurred in adherent cell populations from both oil-elicited and oil-elicited infected
PEC.

Such reductions in specific enzyme activity were not

attributable to an increase in adherent cell protein as a
result of drug treatment.

Catalase activity in resident

Table III.

The effect of SM-1213 treatment of peritoneal exudate cells (PEC) on
adherent cell enzyme activity

PEC type!?_

SM-1213
concentration
(ng/ml)

Adherent cell enzyme activity
(units/mg Erotein)a
N-AcetylCatalase
Peroxidase
glucosaminidase

Resident

0
1.0

31.85 ± 0.69£
32.34 ± 0.46

Oil-elicited

0
0.1
1.0

40.76 ± 2.64
25.97 ± 0.83*~
27.79 ± 1. 95*

Oil-elicited
infected

0
0.1
1.0

61.97 ± 1. 35
36.37 ± 1.95*
51.02 ± 1.25*

10.23 ± 0.22
11.00 ± 0.33

1. 86 ± 0.21
2.14 ± 0.09

0.55 ± 0.07
0.45 ± 0.08
0.64 ± 0.07

1. 99 ± 0.11
1.40 ± 0.14
1.62 ± 0.08

N.D.~

1. 76 ± 0.25
1.96 ± 0.14
1. 96 ± 0.08

a) Enzyme units and mg protein were determined on cell lysate supernatants from the
isolated adherent cell fraction.
b) Resident cells were obtained from guinea pigs on the day of the experiment by peritoneal lavage. Oil-elicited PEC were obtained by peritoneal lavage 72 h after
elicitation of cells by i.p. injection of mineral oil. Oil-elicited PEC infected
with yeast phase C. albicans at the time of PEC plating were designated as oil-elicited infected PEC.--All samples were incubated with the designated concentrations of
drug for 6 h. Culture fluid and non-adherent cells were removed prior to lysis and
assay of adherent cell lysate supernatants.
c) Data represent means ± SEM of triplicate dishes and are derived from one representative experiment for each PEC type.
d) An asterisk (*) denotes P < 0.05 between control (0 ng/ml) and drug-treated. PEC
samples.
e) Not determined.
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PEC was not affected by drug treatment (Table III).

No

significant drug-induced reductions in catalase activity
were observed for any cell type incubated for less than
6 h or for PEC-0 treated with >10 ng SM-1213/ml (data not
shown).

The observed drug-induced reduction in catalase

specific activity in oil-elicited PEC types was selective,
in that peroxidase levels were not affected, nor were

levels of N-acetylglucosaminidase, a marker lysosomal
enzyme (Table III).

PEC lactate dehydrogenase activity

and protein content (data not shown) were not significantly
affected by drug treatment.
Candida incubated for 6 h in medium alone followed
i

by treatment with 0.5% NI for 10 min exhibited no leakage
of catalase into the extracellular medium.

No detectable

protein was released from Candida into the extracellular
medium.

Also, protein content was not greater in super-

natants from infected adherent cell lysates than in supernatants from uninfected adherent cell lysates when PEC-0
were derived from the same experimental animal.
The drug-induced reduction of adherent cell catalase activity was not associated with a corresponding
enhancement of non-adherent cell or extracellular activity
(Figure 4) , and thus could not be identified as representing a loss of cell adherence or of transfer of catalase
from the intra- to the extracellular compartment.

No

so

Figure 4. The effect of SM-1213 treatment of
PEC-0 on adherent cell, non-adherent cell, and extracellular catalase activities in vitro. PEC-0 were
incubated with the designated-concentrations of drug
for 6 h. Experimental conditions were as described
in Methods section. Data represent the mean ± SEM of
triplicate or quadruplicate dishes and were derived
from one representative experiment. Significant druginduced reductions in catalase activity were observed
for the adherent cell population only, as indicated
at right by an asterisk (*).
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direct drug effect on standard bovine liver catalase activity was observed when drug was added during enzyme assay.
G.

Effect of SM-1213 Pre-incubation of PEC-0 on NBT Reduction by Phagocytes after Ingestion of Opsonized

c.

albicans
An explanation for the reduction of catalase ac-

tivity observed in drug-treated PEC-0 and the relationship
of this reduction to the production of active oxygen species responsible for candidal killing by phagocytes was
suggested by the work of Kono and Fridovich (57).

They

demonstrated that catalase activity was reduced by the
action of 02 on the heme pqrtion of the enzyme.

Similarly,

the author has observed a reduction in catalase activity
during exposure of the enzyme to a xanthine-xanthine oxidase superoxide generating system (unpublished observation,
C.J. Morrison).

It was therefore decided to examine the

effect of SM-1213 treatment of phagocytes on their ability
to generate 02 and H2 0 2

~

vitro.

In all studies regarding

the production of active oxygen species by phagocytes, oilelicited PEC were pre-incubated

~

vitro in the presence or

absence of drug for the indicated time intervals, washed,
and then exposed to the assay conditions described.
Figure 5 depicts the significantly enhanced production of 02 by PEC-0 pre-incubated with SM-1213, as
assessed by NBT reduction during phagocytosis of opsonized
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Figure 5. The effect of SM-1213 pre-incubation of PEC-0 on NBT reduction by phagocytes during
ingestion of opsonized c. albicans. PEC-0 were preincubated for 2 or 6 h With the designated concentrations of drug, washed, and adherent PEC-0 were exposed
to the NBT assay system with opsonized Candida as
phagocytic stimulus. Data represent the mean ± SEM
of triplicate dishes and were derived from one representative experiment. Significant drug-induced enhancement of SOD-inhibitable NBT reduction was observed, as indicated at right by an asterisk (*).
UNO = undetectable SOD-inhibitable NBT reduction.
BSA or boiled SOD did not inhibit NBT reduction;
Candida alone did not reduce NBT.
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candida.

Although 02 production was reduced at 6 h rela-

tive to 2 h, SM-1213 treatment enhanced 02 production by
PEC-0 at both time intervals (Figure 5).

o;

The reduction in

generation at 6 h was not due to a loss of PEC-0 via-

bility as assessed by trypan blue dye exclusion or due to
a reduced phagocytic capacity.

SOD equally inhibited NBT

reduction in control and drug-treated samples and druginduced differences in SOD-inhibitable NBT reduction were,
therefore, not due to a drug action on SOD itself.
In order to more fully understand the mechanisms
whereby PEC-0 kill Candida, it was of interest to examine
the location of 02

product~on

by PEC-0, that is, to differ-

entiate between NBT reduction occurring extracellularly
and that associated with the cell.

This was accomplished

by transferring the NBT reaction fluid from the culture
dishes to test tubes and by stopping the reaction separately in the tubes (extracellular) and dishes (cell-associated) after the 15 min incubation period.

The majority of

NBT reduction occurred extracellularly and accounted for
an average of 74.4% of the total NBT reduced by all samples.
In samples pre-incubated in the absence of drug for 6 h,
100% of the SOD-inhibitable reduction of NBT occurred
extracellularly.

In contrast, in samples treated with

1 ng SM-1213/ml, 66% of the SOD-inhibitable reduction of
NBT occurred extracellularly.

NBT reduction was not in-
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hibited by boiled SOD or by BSA.

Candida alone did not

reduce NBT.
H.

Effect of SM-1213 Pre-incubation of PEC-0 on NBT and
FCC Reduction by Phagocytes after Ingestion of Opsonized Zymosan
PEC-0 were pre-incubated in the presence or absence

of SM-1213 for 2 or 6 h, washed, and exposed to the NBT
assay system with opsonized zymosan as phagocytic stimulus.
NBT reduction by PEC-0 pre-incubated with SM-1213 was enhanced relative to PEC-0 pre-incubated in the absence of
drug, as depicted in Figure 6.
ment was most pronounced

a~

This drug-induced enhance-

the 1.0 ng/ml dose level.

Opsonized zymosan (Figure 6) stimulated a greater reduction
of NBT by PEC-0 than opsonized Candida (Figure 5) and was
therefore used as the phagocytic stimulus in the remaining
experiments.
In order to confirm the observed drug-induced
enhancement of 02 production by PEC-0, a second method
typically used to assess 02 production by phagocytes,
ferricytochrome c (FCC) reduction, was utilized.

Results

were expressed as nmoles FCC reduced per mg protein per
90 min to conform to the standard reporting format.

As

Figure 7 depicts, pre-incubation of PEC-0 with SM-1213
resulted in a significantly enhanced reduction of FCC by
phagocytes during ingestion of opsonized zymosan.

As in
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Figure 6. The effect of SM-1213 pre-incubation of PEC-0 on NBT reduction by phagocytes during
ingestion of opsonized zymosan particles. PEC-0 were
pre-incubated for 2 or 6 h with the designated concentrations of drug, washed, and adherent PEC-0 were
exposed to the NBT assay system with opsonized zymosan
as phagocytic stimulus. Data represent means ± SEM
of duplicate or triplicate dishes and were derived
from one representative experiment. Significant druginduced enhancement of SOD-inhibitable NBT reduction
was observed, as indicated at right by an asterisk (*).
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Figure 7. The effect of SM-1213 pre-incubation of PEC-0 on ferricytochrome c reduction by phagocytes during ingestion of opsonized zymosan particles.
PEC-0 were pre-incubated for 2 or 6 h in the presence or absence of SM-1213,
washed, and adherent PEC-0 were exposed to the FCC assay system with opsonized
zymosan as phagocytic stimulus. Data represent means ± SEM of triplicate dishes
and were derived from one experiment. Significant drug-induced enhancement of
SOD-inhibitable FCC reduction was observed, as denoted below by an asterisk (*).
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Figures 5 and 6, although

Oz

production was reduced at 6 h

relative to 2 h, SM-1213 treatment enhanced 02 production
by PEC-0 at both time intervals (Figure 7) .
I.

Effects of SM-1213 Treatment of PEC-0 or PEC-0 Lysates
on NADPH-dependent Superoxide Generation by Cell Lysates
It is generally agreed that the enzyme primarily

responsible for superoxide production by stimulated phagocytes is a cyanide-insensitive oxidase which utilizes a
reduced pyridine nucleotide as substrate (8,16,91).

NAD-

(P)H oxidase has been demonstrated to be involved in

Oz

production when phagocytes; are stimulated by membraneperturbing agents such as phorbol myristate acetate (8),
or by phagocytic particles such as opsonized zymosan (91).
In order to determine whether a drug-mediated effect on
this enzyme was responsible for the observed enhancement
of 02 production by PEC-0 pre-incubated with SM-1213,
an examination of NADPH-dependent FCC and NBT reduction
was initiated.
PEC-0 were pre-incubated in the absence or presence of SM-1213 for various time intervals and washed
prior to stimulation with opsonized zymosan.

Following

stimulation, PEC-0 were lysed with detergent and cell
lysates were assayed for NADPH-dependent NBT or FCC reduction in the presence of exogenously added NADPH.
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Figure 8 depicts the significant enhancement of
NADPH-dependent FCC reduction by lysates from PEC-0
incubated with SM-1213 for

6

h.

pre~

Treatment at the 1.0 ng/ml

drug concentration enhanced NADPH-dependent FCC reduction
after 2 h to a level which approached significance (0.1
p

>

>

0.05).
A significant enhancement of NADPH-dependent NBT

reduction by cell lysates was also observed (Figure 9)
when PEC-0 were pre-incubated for 6 h with 0.1 or 1.0 ng
SM-1213/ml prior to cell lysis.

No significant drug-

induced increase in 02 production was observed when PEC-0
were pre-incubated for

les~

than 6 h (Figure 9).

PEC-0

pre-incubated in the absence of drug for 6 h and receiving
no substrate NADPH at the time of NBT assay demonstrated
relatively minimal NBT reduction (Figure 9).

The reduced

activity observed at 0 h may have resulted from the presence of SOD (75) from minor red blood cell contamination
present in PEC-0 cell suspensions at this time interval
only.
The reduction of 02 production at 6 h relative to
2 h observed for whole cell NBT and FCC reduction (Figures
5, 6, 7) was not observed for 02 production by cell lysates
(Figure 9).

Instead, an increase in 02 production was

observed at 6 h relative to earlier time intervals and only
at 6 h was a significant drug-induced enhancement of NBT
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Figure 8. Drug enhancement of NADPH-dependent
FCC reduction by cell lysates from PEC-0 pre-incubated
with SM-1213. PEC-0 were pre-incubated in the presence or absence of SM-1213 for 2 or 6 h and adherent
PEC-0 were washed prior to stimulation with opsonized
zymosan and cell lysis. Cell lysates were assayed for
FCC reduction as described in Methods section. Data
represent means ± SEM of triplicate dishes and were
derived from one experiment. Significant drug-induced
enhancement of SOD-inhibitable NADPH-dependent FCC
reduction was observed, as denoted at right by an
asterisk (*).
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Figure 9. Time-dependent drug enhancement of NADPH-dependent NBT reduction by cell lysates from PEC-0 pre-incubated with SM-1213. PEC-0 were preincubated in the presence or absence of SM-1213 for 2, 4 or 6 h and adherent
PEC-0 were washed prior to stimulation with opsonized zymosan and cell lysis.
Cell lysates were assayed for NBT reduction as described in Methods section. At
0 h, PEC-0 in suspension (consisting of 77% macrophages, 3% PMN and 20% lymphocytes) were incubated with the opsonized zymosan stimulant mixture, washed by
centrifugation in PBS and lysed. Lysates were assayed for NBT reduction as described in Methods section. Cell lysates from PEC-0 pre-incubated in the absence
of drug for 6 h and receiving no substrate NADPH at the time of NBT assay are
designated below as NO NADPH. An as,terisk (*) denotes P < 0.05 between samples
obtained from PEC-0 pre-incubated in the absence of drug and those from PEC-0
pre-incubated in the presence of drug. Data represent means ± SEM of the number
of experiments denoted in parentheses ( ).
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reduction observed (Figure 9).
In order to determine whether the time-dependen.t
nature of the observed drug effect was a result of the
time PEC-0 were exposed to SM-1213 or whether it was a
result of the time PEC-0 were held in culture, PEC-0 were
pre-incubated for 2 or 6 h in the absence of drug prior to
stimulation with opsonized zymosan and cell lysis.

Cell

lysates were then assayed for NBT reduction in the presence or absence of SM-1213.
Table IV compares NADPH-dependent NBT reduction by
cell lysates from PEC-0 pre-incubated with SM-1213 to cell
lysates from PEC-0 pre-incpbated without SM-1213 but receiving drug during NBT assay.

When PEC-0 were pre-incu-

bated for 6 h in the presence or absence of SM-1213, significant drug-induced enhancement of NBT reduction occurred
in all drug-treated samples (Table IV).

Pre-incubation of

PEC-0 with drug resulted in an average percent increase in
NBT reduction by cell lysates of 50.2% relative to cell
lysates from PEC-0 pre-incubated in the absence of drug.
Pre-incubation of PEC-0 without drug followed by incubation
of cell lysates with drug during NBT assay resulted in an
average percent increase in NBT reduction by cell lysates
of 28.7% relative to cell lysates from PEC-0 pre-incubated
in the absence of drug.

When comparing NBT reduction by

cell lysates from PEC-0 pre-incubated with SM-1213 to cell

Table IV.

NADPH-dependent reduction of NBT by cell lysates from oil-elicited PEC
(PEC-0)
nmoles NBT reduced710~ cells715 m1n
I

SM-1213
concentration
(ng/ml)

0

PEC-0 pre-incubated for:
6 h
with druga

(% drug
effect)£

58.59 ± 1.12e

6 h
w/o drug£

(% drug
effect)b

55.80 ± 2.79

(% increase
with vs. w/o
drug during
pre-incubation)d

(50 0)

0.1

87.05 ± 3.9l*f

(48.6)

69.75 ± 3.91*

(25.0)

(24. 8)

1.0

88.72 ± 3.91*

(51. 4)

75.33 ± 6.70*

(35.0)

( 17. 8)

10.0

88.16 ± 5.02*

(50. 5)

70.31 ± 3.91*

(26.0)

(25.4)

(28.7)

(22.7)

Average

(50.2)

a) PEC-0 were pre-incubated with the designated concentrations of SM-1213 for 6 h and
washed to remove residual drug prior to stimulation with opsonized zymosan and cell
lysis. Cell lysates were assayed for NBT reduction as described in Methods section.
b) % drug effect = nmoles NBT reduced b :dru -treated - control(O n ml) sam les X
100
nmoles NBT reduced by control (0 ng ml samples
·
c) PEC-0 from the same cell source as in a) were pre-incubated in the absence of drug
for 6 h prior to stimulation with opsonized zymosan and cell lysis. Cell lysates
were assayed for NBT reduction in the presence of the designated concentrations of
SM-1213 as described in Methods section.
d) % increase = nmoles NBT reduced by: a) - c) X lOO.
nmoles NBT reduced by c)
e) Mean ± SEM of triplicate dishes from one representative experiment.
0'1
f) An asterisk (*) denotes P < 0.05 between untreated PEC (0 ng/ml) and
CX)
drug-treated PEC samples.
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lysates treated with drug during NBT assay only, NBT reduction was increased an average of 22.7% in cell lysates
from PEC-0 pre-incubated with drug (Table IV).

No sig-

nificant drug enhancement of NBT reduction was observed
for either type of cell lysate after pre-incubation for
less than 6 h (i.e., 2 h with drug:

0 ng/ml, 62.50 ± 1.00;

0.1 ng/ml, 68.08 ± 3.08; 1.0 ng/ml, 61.38 ± 1.42.

drug:

2 h w/o

0 ng/ml, 62.50 ± 1.12; 0.1 ng/ml, 65.29 ± 3.35;

1.0 ng/ml, 64.17 ± 2.23).

When resident PEC were tested in the same manner,
no significant drug-enhanced 02 production was observed in
either cell lysate type after either 2 or 6 h of preincubation (Table V).

NBT reduction was greater in oil-

elicited PEC lysates (Table IV) relative to cell lysates
from resident PEC (Table V) , an effect which was most pronounced in lysates from PEC pre-incubated for 6 h (cell
lysates from PEC-0 pre-incubated in the absence of drug
were increased an average of 19.7%, while cell lysates
treated with drug during NBT assay or cell lysates from
PEC-0 pre-incubated in the presence of drug were increased
an average of 82.9%).
J.

Effect of SM-1213 Pre-incubation of PEC-0 on Hydrogen
Peroxide Generation
The results presented thus far suggest that SM-1213

treatment of PEC-0 or of PEC-0 lysates induces an increase

Table

v.

NADPH-dependent reduction of NBT by cell lysates from resident PEC
(PEC-r)

nmoles NBT reduced/10 6 cells/15 min
SM-1213
concentration
(ng/ml)

PEC-r pre-incubated for:
2 h
with

6 h
with drug~

drug~

Experiment #1

6 h
w/o drugb

Experiment #2

59 • 8 6 ± 1. 55.£

55.21 ± 3.10

41.85 ± 2.79

0.1

54.70 ± 0.52

47.99 ± 3.10

45.20 ± 1.67

1.0

53.15 ± 2.06

47.99 ± 1.55

35.71 ± 2.23

0

a) PEC-r were pre-incubated with the designated concentrations of SM-1213 for 2
or 6 h and washed to remove residual drug prior to cell lysis. Cell lysates
were assayed for NBT reduction as described in Methods section.
b) PEC-r were pre-incubated in the absence of drug for 6 h prior to cell lysis.
Cell lysates were assayed for NBT reduction in the presence of SM-1213 as
described in Methods section.
c) Mean ± SEM of duplicate or triplicate dishes.
-..J
0

71
in 02 production by enhancing the activity of phagocyte
NAD(P}H oxidase.

It follows that H2 0 2 generation would·

also be increased by SM-1213 treatment of PEC-0, since
dismutation of 02 produced by phagocytes results in the
production of H2 0 2 (104}.

It was decided to examine H2 0 2

generation by SM-1213-treated PEC-0, since the production
of this active oxygen species by phagocytes has been shown
to be involved in the tumoricidal (92,97}, as well as the
microbicidal (87,95,118}, activity of phagocytes.

In

addition, the possible modulation of phagocyte H2 0 2 production by another related immunomodulatory drug, muramyl
dipeptide (MOP}, was assessed, since this agent increases
the NAD(P}H oxidase activity of phagocytes (51}.
PEC-0 were pre-incubated for 2 or 6 h in the presence of SM-1213 or MOP, washed to remove residual drug,
stimulated with opsonized zymosan, and assayed for extracellular H2 0 2 production by the oxidation of phenol red.
Extracellular H2 0 2 production by phagocytes was enhanced
by pre-incubation for 2 h with 1 ng/ml of either drug and
by pre-incubation for 6 h with 0.1 ng MDP/ml or 1 ng SM1213/ml (Figure 10}.
H2 0 2 production by cell lysates, assessed by the
oxidation of phenol red after disruption of PEC-0 with
detergent, was significantly increased in samples treated
with either drug at all concentrations tested (Figure 11}.

Figure 10. The effect of SM-1213 pre-incubation of PEC-0 on extracellular
H202 production during phagocytosis of opsonized zymosan. PEC-0 were pre-incubated
for 2 or 6 h with the designated concentrations of SM-1213, washed to remove residual drug, and adherent PEC-0 were exposed to the phenol red assay system with
opsonized zymosan as phagocytic stimulus. After incubation for 30 min, medium was
assessed for extracellular H20 2 production as described in Methods section. Data
represent means ± SEM of triplicate dishes and were derived from one representative
experiment. An asterisk (*) denoted P < 0.05 between samples from PEC-0 preincubated in the absence of drug and those from PEC-0 pre-incubated in the presence
of drug.
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Figure 11. The effect of SM-1213 pre-incubation of PEC-0 on cell lysate
H2 0 2 production following phagocytosis of opsonized zymosan. Experimental conditions were as in Figure 10, except PEC-0 were lysed with detergent following
ingestion of opsonized zymosan and exposed to the phenol red assay system. Cell
lysates were assessed for H2 0 2 production as described in Methods section. Data
represent means ± SEM of triplicate dishes and were derived from one experiment.
An asterisk (*} denotes P < 0.05 between samples from PEC-0 pre-incubated in the
absence of drug and those from PEC-0 pre-incubated in the presence of drug.
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In samples from PEC-0 pre-incubated for 6 h in the
absence of drug, 85.7% of the total H2o 2 produced by phagocytes was extracellular, while 14.3% was produced by cell
lysates.

In contrast, in all samples from PEC-0 pre-

incubated for 6 h in the presence of drug (MDP or SM-1213} ,
an average of 56.4% of the total H20 2 produced was extracellular (range 47.1-66.1%}, while 43.6% was produced by
cell lysates (range 33.9-52.9%}.

While extracellular H20 2

production either increased or decreased between 2 and 6 h,
H20 2 production by cell lysates increased in all drugtreated samples an average of 30% during this interval
(Figures 10 and 11}.

H2o2 ;production by samples from

PEC-0 pre-incubated in the absence of drug remained unchanged over time (Figure 11}.
The addition of catalase to the H20 2 assay mixture
resulted in a 94.6% reduction in phenol red oxidation,
while boiled catalase reduced oxidation by 31.6% and SOD
increased oxidation by 26%.
K.

Effect of SM-1213 on the Candidacidal Activity of the
NADPH-NAD(P}H Oxidase System
Since SM-1213 treatment enhanced the NADPH-depen-

dent production of 02 by PEC-0 1ysates (Figure 9), it was
decided to examine the effect of SM-1213 on the NADPHdependent candidacida1 activity of PEC-0 homogenates.
PEC-0 were pre-incubated in vitro for 2 or 6 h in
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the absence of drug, stimulated with opsonized zymosan and
homogenized.

Cell homogenates were tested for SOD-inhibit-

able, NADPH-dependent candidal killing in the presence or
absence of SM-1213.

The results are depicted in Figure 12.

Significant drug-induced enhancement of SOD-inhibitable
candidal killing was observed by cell homogenates from
PEC-0 pre-incubated for 2 or 6 h in the absence of drug
and subsequently treated with 0.1 or 1 ng SM-1213/ml during
the killing assay (Figure 12).

Cell homogenates from PEC-0

pre-incubated for 6 h in the absence of drug and subsequently treated with 10 ng SM-1213/ml also demonstrated
enhanced candidal killing. ; When cell homogenates were
boiled before addition to Candida or when no NADPH was
added to the incubation mixture, some killing was observed
(Figure 12).

SM-1213 did not enhance killing by boiled

cell homogenates or by samples receiving no NADPH.
The enhanced killing of Candida by drug-treated
cell homogenates was not an artifact resulting from the
increased clumping or sticking together of yeast cells in
the presence of drug as determined by phase contrast microscopy.
Candidal killing by cell homogenates in the presence or absence of SM-1213 was also assessed by the methylene blue dye exclusion technique (63).

Although overall

candidacidal activity in all samples was lower (4-17.5%

Figure 12. The effect of SM-1213 on NADPH-dependent candida! killing by
cell homogenates. PEC-0 were pre-incubated in vitro for 2 or 6 h in the absence
of drug prior to stimulation with opsonized zymosan and cell homogenization.
Candida yeast cells were incubated with cell homogenates and substrate NADPH for
90 min in the absence or presence of the designated concentrations of SM-1213.
After incubation, serial dilutions of samples were plated on SDA for enumeration
of cfu 48 h later. Cell homogenates from PEC-0 pre-incubated in the absence of
drug and receiving no NADPH during incubation are designated below as NO NADPH.
Cell homogenates which were boiled for 10 min before incubation with Candida in
the assay system are designated below as BL. Data represent the mean percent
SOD-inhibitable Candida killed relat~ve to Candida incubated in buffer alone
from duplicate d~shes ± SEM and were derived from one experiment. An asterisk
(*) denotes P < 0.05 between drug-treated and untreated (0 ng/ml) samples.
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dead), the enhancement of candidal killing by drug-treated
cell homogenates or cell lysates (lysed with 0.5% NI) was
evident using this assay system (P < 0.05). The methylene
blue assay system may, however, have given artificially
high values for the number of apparently viable Candida.
For example, others have demonstrated that as many as 27%
of Candida killed by activated mouse macrophages (as assayed by microcolony formation) did not lose their ability to
exclude dye during the assay period (45).

CHAPTER IV
DISCUSSION
In the absence of PEC, SM-1213 had no direct fungistatic or fungicidal effect against the yeast or hyphal
form of Candida albicans (Table I).

However, SM-1213 was

found to be effective in inducing PEC-0 to inhibit the
intracellular formation and elongation of

~

albicans

hyphae (Figure 2) and to reduce the percentage of viable
Candida remaining after phagocytosis (Table II).

Signif-

icant drug-induced candidastatic and candidacidal effects
were also observed when PEC-o were pre-incubated with
SM-1213 and washed prior to infection with Candida (Figure
3, Table II).

These results indicate that SM-1213 was

able to potentiate one or more candidacidal processes
expressed by PEC-0.
When PEC-0 were infected and incubated with SM1213, the most significant drug-induced reductions in
hyphal growth and candida! viability occurred at the 1
ng/ml drug level (Figure 2, Table II).

Higher or lower

concentrations of drug were less effective, reflecting the
bell-shaped dose response curve frequently observed for
irnrnunomodulatory drugs (35,40).
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In addition, others (12)
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have reported that SM-1213 enhanced the effectiveness of
mouse resident peritoneal rnacrophages against Mycobacterium
tuberculosis when macrophages were treated with SM-1213
concentrations as low as 0.01 ng/ml and as high as 100
ng/ml.

However, the most effective antimycobacterial drug

concentration examined by a dose response curve was 1 ng/ml
(12).

Also, Hadden

~

al (40) reported that SM-1213 was

capable of significantly increasing the killing of intracellular Listeria monocytogenes within oil-elicited guinea
pig macrophages treated with the lowest SM-1213 concentration tested, 0.12

~g/ml.

While PEC-0 treatea with 10 ng SM-1213/ml did not
kill a greater percentage of Candida than untreated (0
ng/ml) PEC-0 (Table II), intracellular inhibition of hyphal
growth, although not significant, was suggested (Figure 2)
and may reflect the initiation of hyphal injury.

Hyphal

inhibition was greatest relative to controls at 4 h, as
opposed to at 6 h, in PEC-0 receiving lower drug concentrations (Figure 2) •

It is not known at present whether

SM-1213 is taken into and accumulated within PEC-0 over
time.

Although requested from Greenwich Pharmaceuticals,

radiolabelled SM-1213 was not available at the time the
present studies were conducted.

If, however, SM-1213 was

taken into and accumulated within PEC-0, then PEC-0 treated
with 10 ng SM-1213/ml could attain effectively candida-
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static drug levels at an earlier time interval (4 h) than
PEC-0 treated with lower drug concentrations.

The mild

reduction in candidastatic action at 6 h relative to at
4 h was not due to a toxic effect of SM-1213 upon phagocytes at the 10 ng/ml concentration for several reasons:
1) uninfected PEC-0 incubated in the presence of SM-1213
were >97% viable by trypan blue dye exclusion after 6 h
in culture; 2) others have demonstrated that the antibacterial activities of macrophages were significantly
enhanced at this (12) or higher (40) drug concentrations;
and 3) others have reported that drug concentrations 101000 times higher did not

~ffect

the viability of WI-38

cells (37) or macrophage monolayers (40).
The occurrence of maximal drug-induced effects at
6 h for PEC-0 treated with 0.1-1 ng SM-1213/ml suggests
that modulation of PEC-0 anticandidal mechanisms are either
initiated at an earlier time interval but enacted slowly
(over 6 h) or not initiated until 6 h for reasons which
may include the unresponsiveness of PEC-0 to drug action
at earlier intervals or the accumulation or processing of
drug by PEC-0, resulting in drug effectiveness at 6 h.
Others have suggested that a small but sustained oxidative
attack by phagocytes results in effective target cell
injury and death over time (97,118).

Upon phagocytosis of

opsonized Candida, PEC-0 pre-incubated in the absence or
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presence of drug were capable of producing as much or more
Oi after 2 h in culture as after 6 h in culture

(Figure~).

PEC-0 pre-incubated in the presence of SM-1213 demonstrated
enhanced

02

production at both time intervals relative to

controls (Figure 5).

These data suggest that SM-1213 can

enhance the oxidative anticandidal mechanisms of PEC-0
after only 2 h of drug treatment and that sustained oxidative injury may be responsible for the observed candidastatic and candidacidal effects at 6 h.

However, the

effect of culturing PEC-0 over time may also influence
candidacidal mechanisms and the modulation of these mechanisms by SM-1213.
When PEC-0 were pre-incubated with SM-1213 for
6 h and washed prior to infection, all drug levels tested
induced significant and relatively similar anticandidal
effects (Figure 3, Table II).

It is not surprising that

PEC-0 pre-incubated in the presence of drug prior to the
introduction of an infectious agent were equally receptive
to modification by all levels of drug rather than one or
two levels as observed for PEC-0 exposed to drug at the
time of infection (Figure 2, Table II).

Other immune-

modulatory agents, such as MOP and LPS, are totally ineffective stimulators of an enhanced oxidative response,
unless phagocytes are pre-incubated with these agents for
15 min to 4 h prior to the addition of a phagocytic or
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chemical stimulus (51,100).

Therefore, SM-1213 has the

added capacity to enhance the candidacidal action of PEC-0
when administered at the time of phagocyte infection (Figure 2, Table II).

These actions can be related to in vivo

effects as well, since MDP is most effective in enhancing
the survival of mice infected intravenously with

~ ~

cans when administered prophylactically 18 h prior to
inoculation (23) while SM-1213 is most effective when drug
is given 3 to 5 days after infection (83).
The mechanism whereby SM-1213 enters into PEC-0
pre-incubated in the presence of drug, as opposed to PEC-0
exposed to drug during

in~ection,

may provide an explana-

tion for the observed differences in PEC-0 candidacidal
effectiveness at the 10 ng/ml drug level.

For example,

PEC-0 pre-incubated in the presence of SM-1213 may use
pinocytotic or sugar transfer mechanisms to transport
SM-1213 into PEC-0.

PEC-0 exposed to SM-1213 at the time

of infection would also take drug into the phagocytic
vacuole along with Candida cells.

Within phagocytic vacu-

oles, the drug may be retained in high concentration and
remain localized in this cellular compartment.
Alternatively, during pre-incubation SM-1213 may
not enter the cell, but may bind to the exterior of or
induce a modification of the cell membrane.

The lyrnpho-

kine, interferon-y, has been reported to be an effective
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stimulator of macrophage reactive metabolite production
when macrophages are exposed for as little as 10 min to.
this agent, washed, and stimulated with PMA three days
later (94).

Therefore, the exposure of PEC-0 to SM-1213,

followed by washing of the cells, may provide stimulation
without subsequent inhibition of candidacidal mechanisms as
a result of excess drug concentration.
At the time of infection, pre-incubated PEC-0 were
composed of an entirely adherent cell population, while nonpre-incubated PEC-0 were composed of freshly plated adherent and non-adherent cells.

It was therefore conceivable

that differences in PEC-0 qell types present or the state
of cell adherence at the time of initial candida! infection
caused differences in the observed candidacidal activity of
pre-incubated versus non-pre-incubated PEC-0.

However,

this was probably not the case, since PEC-0 allowed to adhere to culture dishes for 2 h and washed prior to infection
gave virtually identical results to those obtained for unseparated PEC-0 (unpublished observation,

c.

J. Morrison).

After 6 h of pre-incubation in the presence or
absence of drug, only a 2 h incubation period was required
for PEC-0 to kill percentages of Candida almost as great or
greater than PEC-0 incubated with Candida for 6 h (Table
II).

This suggests that, once PEC-0 are primed by pre-

incubation in culture for 6 h, they become more effectively
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candidacidal upon presentation of the infecting microorganism.

However, there is also evidence to indicate

that the candidacidal (59) and microbicidal (88) activities
of phagocytes may actually be reduced by time in culture
and, as depicted in Figure 5, upon stimulation with opsonized Candida the production of 02 by PEC-0 cultured for
6 h was reduced relative to those cultured for 2 h.

Since

02 production by phagocytes has been correlated to their
candidacidal activity (118), a reduced production of 02 at
6 h should result in a reduced anticandidal capacity for
PEC-0 at this time interval relative to at 2 h.

Indeed,

for PEC-0 pre-incubated in .the absence of drug, no 02 production was observed at 6 h upon addition of opsonized
Candida (Figure 5), although >97% of PEC-0 were viable.
Whether this reduction at 6 h was due to a non-responsiveness of PEC-0 at this time interval or whether Candida
actively "turned off" or failed to initiate
by these cells is not known.

02

production

However, PEC-0 pre-incubated

in the absence of drug were able to respond oxidatively at
6 h when opsonized zymosan was used as the phagocytic
stimulus (Figures 6 and 7), although the response was
somewhat reduced relative to at 2 h.
PEC-0 were less responsive to

~

This indicates that

albicans than to zymosan

at 6 h due to an inherent property of the microbe.
Others have demonstrated that, although two candidal

88
species were phagocytosed equally,

~

albicans stimulated

only half the quantity of 02 production by macrophages as
the less virulent species,

~

parapsilosis (118).

Also,

the survival of the intracellular pathogen, Toxoplasma
gondii, within human macrophages was reported to be the
result of ingestion of the organism without a stimulation
of the production of reactive oxygen intermediates (127).
Similarly, in studies presented here, PEC-0 pre-incubated
in the absence of drug phagocytosed opsonized Candida
normally at 6 h (unpublished observation, C. J. Morrison),
although no stimulation of phagocyte

o;

production was

detected.
The ability of opsonized Candida to stimulate 02
production by control PEC-0, pre-incubated in the absence
of drug for 2 h, may relate to a state of PEC-0 "pseudoactivation" as a result of agitation during cell harvesting
and plating.

Activated macrophages have been shown to

generate increased amounts of reactive oxygen metabolites
upon phagocytosis of Candida (118), and thus the 2 h pseudoactivation of phagocytes might result in a priming of
control PEC-0 for an enhanced oxidative response upon
stimulation with Candida.

It is hypothesized that, after

6 h in culture, the initial pseudo-activation of PEC-0
would diminish so that opsonized Candida would no longer
stimulate an oxidative response.

Cultured human macro-
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phages have been reported by others (86,94) to gradually
lose H2 0 2 -producing capacity with time in culture, while
resident mouse macrophages have been reported to gradually
increase this capacity over a 72-h period (87).

Others

have reported an increase followed by a decrease in H2 o 2 producing capacity for human macrophages (89).
Results of studies with monocytes from a patient
with X-linked CGD and his heterozygous mother were reported
to indicate that oxygen-dependent mechanisms were important
to the early and efficient killing of

~

gondii, but that

non-oxidative reserve mechanisms which were less efficient
were capable of killing this microbe (127).

Similar re-

sults were reported for the killing of Leishmania donovani
by CGD monocytes and, upon exposure to lymphokines, CGD
macrophages (86).

The observed killing of Candida at 6 h

by PEC-0 pre-incubated in the absence of drug (Table II)
without detectable 02 production (Figure 5) may, therefore,
be due to the non-oxidative killing mechanisms of phagocytes.

PEC-0 pre-incubated in the presence of drug demon-

strated a reduced but substantial production of 02 at 6 h
relative to at 2 h (Figure 5).

Drug-treated PEC-0 may

therefore utilize both oxidative and non-oxidative killing
mechanisms, resulting in the observed overall enhancement
of candidal killing for drug-treated PEC-0 relative to
control PEC-0 (Table II).
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Candida cells may also possess protective mechanisms whereby they "turn off" the anticandidal systems
macrophages.

o~

Ozato and Uesaka (99) observed that intra-

cellular candida! growth was temporarily inhibited by
casein-elicited macrophages but, after 2-3 h, candida!
growth resumed, resulting in the outgrowth and survival of
Candida cells.

The production of endogenous scavengers of

reactive oxygen metabolites such as catalase or superoxide
dismutase (SOD) may be induced in microorganisms exposed
to high oxygen tensions (38).

Therefore, Candida

~ay

interfere with the anticandidal capacities of macrophages
via the production of

thes~

enzymes.

As detailed in the

introduction to this .paper, candida! catalase or SOD in
and of itself may not be sufficient to protect fungi from
damage by external oxygen metabolites (118).

However, the

exogenous addition of catalase or SOD to macrophages ingesting Candida can inhibit phagocyte candidacidal activity
(118) and, in conjunction with PMN (77) or macrophages
(88), microbial or phagocyte catalase may antagonize phagocyte-mediated killing.

For example, Murray

!! al (88)

reported an increase in intracellular macrophage catalase
activity with time in culture that was associated with a
decreased ability of phagocytes to kill

~

gondii.

In

studies concerning the effect of SM-1213 on PEC-0 catalase
activity, no increase in phagocyte catalase activity was
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observed for resident or oil-elicited PEC between 2 and
6 h of culture (unpublished observation,

c.

J. Morrison).

Although no increase in catalase activity was observed
over time, control (0 ng/ml) PEC-0 demonstrated a 1.5-fold
greater catalase activity when infected relative to uninfected PEC-0 (Table III).

This suggests that, after

phagocytes produce reactive oxygen metabolites in response
to an infectious agent, PEC-0 initiate an enhanced endogenous production of catalase to protect against autooxidative damage (112).

As a result, phagocytes may reduce

their own antimicrobial effectiveness or the antimicrobial
effectiveness of neighboring phagocytes upon autolysis and
release of endogenous catalase.

In

Y!!2,

however, infec-

tions may be resolved as a result of the sequential reinforcement or renewal of phagocytes induced by cellular
immunity (82) or the release of inflammatory mediators
( 12 4) •
Another possible explanation for the moderately
higher catalase activities in the infected versus uninfected PEC-0 may be due to a contribution of catalase
activity from

~

albicans cells.

Sasada and Johnston (118)

suggested that intracandidal SOD or catalase did not affect
the level of detectable 02 produced by macrophages, since
intact, viable Candida showed no detectable release of
these enzymes.

Upon sonication, however, substantial
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candidal catalase (320 U per mg protein) and SOD (21.8 U
per mg protein) activity was detected (118).

It is there-

fore plausible that killing of candidal cells by PEC-0
could result in some leakage of intrafungal catalase.
However, it is unlikely that this is the case, since:

1)

SM-1213-treated PEC-0, which killed more Candida, did not
demonstrate greater catalase activity after cell lysis
than cell lysates from control PEC-0 (Table III); 2) the
increased catalase activity of infected PEC-0 was selective
in that no other enzyme activities tested were increased
(unpublished observation,

c.

J. Morrison, and Table III),

including enzymes comrnonlyi found in fungi (21,119); and
3) infected PEC-0 lysates did not contain more protein
than cell lysates from uninfected PEC-0.
Since an increase in phagocyte catalase activity
has been correlated to a reduced microbicidal capacity
(88), the observed reduced capacity of control PEC-0 to
kill

c. albicans cells (Table II) relative to drug-treated

PEC-0 may be the result of not only a relatively reduced
production of reactive oxygen metabolites (Figures 5,6,7,
10,11), but a relatively greater production of catalase
(Figure 4, Table III) by control PEC-0.

It has been re-

ported by others (57) that 02 can interfere with the heme
portion of the catalase molecule and, as a result, inhibit
its activity.

It may be, then, that the reduction in
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catalase activity observed for drug-treated PEC-0 (Figure
4) is the result of the increased production of

02

by these

cells (Figures 5,6,7).
Resident PEC catalase activities were unaffected
by drug treatment, suggesting that the physiological state
or the state of differentiation of PEC affects PEC responsiveness to drug modulation.

For example, elicited cells

contain a larger proportion of more newly recruited cells
(monocytes) than resident cells, which consist predominantly of established cells (macrophages) (42).

Upon presen-

tation with a phagocytic or chemical stimulus, macrophages
from uninflamed tissues sedrete little

02

or H2 o 2 (49,96),

while cells primed by exposure to inflammatory agents or
lymphocyte mediators secrete high levels of these agents
(49,87).

Therefore, a similar mechanism of PEC priming

may be necessary before maximum SM-1213-induced effects
are invoked.

As reported for MDP (23), SM-1213 adminis-

tered in vivo can also modulate PEC activities in vitro.
PEC-0, obtained on day three from guinea pigs treated

intramuscularly with 10 mg SM-1213 per kg per day for
three days, demonstrated a significant reduction in catalase activity in vitro relative to PEC-0 from animals
which did not receive drug (unpublished observation,
Morrison).

c.

J.

In addition, significant drug-induced reduc-

tions in catalase activity were observed in lysates of the
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phagosomal fraction of homogenized guinea pig PEC-0 treated
with 1 ng SM-1213/ml (P. Gordon, personal communication).
Thus, enhanced intraphagosomal killing of Candida may
result from a reduced catalase activity (or enhanced 02
production?) at this site due to drug treatment of PEC-0.
Although reduced, cytosolic catalase activity may remain
sufficiently active to protect PEC from auto-destruction
due to the leakage of reactive oxygen products from the
phagosomal compartment (112).
The ratio of cell-associated to extracellular 02
and H202 produced was significantly increased in SM-1213treated PEC-0 relative to' control PEC-0.

In control PEC-0,

only 0 to 14% of total oxidative metabolites were cellassociated, while, in drug-treated PEC-0, 34 to 44% were
cell-associated.

Therefore, if oxidative candidacidal

mechanisms are initiated intraphagosomally or intracellularly, drug-treated PEC-0 would be expected to kill a
greater percentage of phagocytosed Candida than untreated
PEC-0.

Also, since 100% of 02 and 86% of H2o 2 produced by

control PEC-0 were.extracellular, not only would intracellular candidal killing be reduced in these cells, but
oxidative damage to surrounding tissues (116) and phagocytes (112) would be increased.

The anticandidal and

anti-inflammatory effects of SM-1213 have been demonstrated
in vivo where intramuscularly infected mice treated with
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SM-1213 produced smaller candida! abscesses relative to
control mice without a concomitant reduction in candidacidal activity (83).
Since SOD is a particularly efficient inhibitor of
candidacidal activity, others have suggested that 02 may
be an especially important reactive oxygen metabolite in
phagocyte anticandidal activity (118).

However, several

researchers have suggested that H2 o2 is the oxidative agent
primarily responsible for phagocyte tumoricidal (92,97)
and microbicidal (86,95) activity.

Both SM-1213 and the

structurally related (Figure 1) immunomodulatory drug, MOP,
effectively enhanced totaliH 2 0 2 production by PEC-0 (Figures 10 and 11) .
6 h.

This enhancement was evident at 2 and at

H2 o 2 production increased between 2 and 6 h by an

average of 30% for PEC-0 pre-incubated in the presence of
drug, while H2 o 2 production remained unchanged over time
for PEC-0 pre-incubated in the absence of drug (Figures 10
and 11).

The increase in H2 o 2 production between 2 and 6 h

correlates with the decrease in detectable 02 produced
during this time interval (Figures 5,6,7).

This suggests

that a greater quantity of 02 is being converted into H2 o2
(reducing detectable 02 levels) at 6 h than at 2 h in drugtreated PEC-0.

These observations would provide an explan-

ation for the reduced production of 02 over time in culture
while PEC-0 viability was intact.

However, this explana-
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tion is relevant to drug-treated PEC-0 only, since no
increase in H2 o 2 production over time was observed for
control PEC-0 (Figures 10 and 11) •

Not all 02 produced

was spontaneously dismutated to H2o 2 , however, since the
addition of SOD to the assay system increased detectable
H202 production by 26%.
In addition to significantly increasing the production of active oxygen species by phagocytes, SM-1213
and MDP can significantly enhance the candidacidal and
candidastatic activity of a cell-free xanthine-xanthine
oxidase (115) 02-generating system (unpublished observations,

c.

J. Morrison).

Complete protection of Candida

from growth inhibition occurred when SOD was included in
the system and substantial (83%) protection occurred when
catalase was included.

Therefore, 02 and H20 2 were impor-

tant mediators of the anticandidal activity of this system.
Scavengers of •OH and singlet oxygen did not protect Candida.

Preliminary experiments indicate that SM-1213 can

enhance the binding of xanthine oxidase to Candida, resulting in an enhanced killing capacity which may be due to
the closer proximity of the 02-producing machinery to the
target cell.

Others (130) have reported that binding of

myeloperoxidase (MPO) to Candida cells is required for MPOmediated killing of fungi and bound eosinophil peroxidase
(EPO) has been demonstrated to effectively enhance the
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microbicidal activity of EPO-mediated killing of T. gondii
( 70) •

It has been reported that soluble cell wall mannans
bind to myeloperoxidase (MPO), and thereby competitively
inhibit MPO-mediated killing of Candida in a dose-dependent
manner (130).

In addition, soluble candidal mannans demon-

strated a similar dose-dependent inhibitory effect on
neutrophil-mediated candidacidal activity (130).

In macro-

phages, which may or may not contain peroxidase activity
(9,22,25), it could be speculated that soluble cell wall

mannans may act as competitive inhibitors for the interaction or binding of the 02-producing NAD(P)H oxidase.

This

would be especially important if close proximity or binding
of the NAD(P)H oxidase to the target cell was required for
NAD(P)H oxidase-mediated candidal killing, as binding is
required for MPO-mediated candidacidal activity (130).
Such binding would allow for the generation of short-lived
02 in close proximity to the target cells, so as to increase the probability that the microorganism would become
substrate for this reactive product and others (130).
Alternatively, the action of NAD(P)H oxidase may be
"turned off" by the binding of soluble cell wall mannans.
This hypothesis would explain the observed absence of 02
production at 6 h by untreated PEC stimulated with opsonized Candida (Figure 5), but would not explain the lack of
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an inhibitory effect at 2 h.

In addition, zymosan, derived

from cell wall components of the yeast Saccharomyces

~

visiae and composed largely of mannan (5), is a potent
stimulator of phagocyte oxidative responses when presented
in the opsonized form (49,104) and to a lesser extent in
the unopsonized form (26).

Also, mannans have been repor-

ted to enhance H2 0 2 production by PMN, while mannose inhibited its production (26).

It is likely, then, that

candidal mannans "turn on" the NAD(P)H oxidase, rather than
turning it off.
Since the oxidative responses of phagocytes can be
stimulated by a number of;soluble agents (92,104,113), the
initiation of the metabolic burst has been reported to
occur at the plasma membrane (43,90).

Molecules which can

stimulate the oxidative burst, such as concanavalin A
(Con A) (110) , are reported to bind to mannose residues of
phagocyte plasma membrane glycoproteins, resulting in a
perturbation that invokes the oxidative burst (104).

It

has been proposed by others (26) that the stimulation of
the oxidative burst of PMN upon presentation with
~

~

albi-

blastospores involves a receptor-ligand interaction

at the plasma membrane.

This hypothesis was based on a

mannose-specific mechanism, since oxidative stimulation by
Candida (but not by PMA or opsonized Sephadex) could be
competitively inhibited upon the addition of mannose (26).
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Since the NAD(P)H oxidase of phagocytes resides in the
plasma membrane (8,91), either it or glycoproteins associated with it may be cross-linked by the binding of C.
albicans or fungal cell wall components. Therefore, ·binding
of Candida to the NAD(P)H oxidase may be required for the
initiation of the oxidative burst and the subsequent killing of Candida by phagocytes via locally produced oxygen
metabolites.
However, binding of Candida to the membrane may
not be sufficient for maximal activation of the NAD(P)H
oxidase.

For example, the stimulation of the oxidative

burst by Con A will not occur unless this agent is in the
tetrameric form (104).

Also, phytohemagglutinin (PHA),

soybean agglutinin (SBA) and Lotus lectin all bind to
macrophages (39), but do not stimulate 02 production (104).
Therefore, the configuration of the stimulating agent, as
well as its binding to phagocytes, influences oxidative
responsiveness.

This was evident in studies conducted here

in that opsonized Candida did not stimulate 02 production
by PEC-0 after 6 h in culture unless PEC-0 had been preincubated in the presence of SM-1213 (Figure 5).

Opson-

ized zymosan, however, could stimulate 02 production at
6 h by control PEC-0 (Figures 6 and 7) and SM-1213 pretreatment of PEC-0 enhanced this production.

Thus, even

though zymosan and Candida contain mannan and/or mannose,
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the manner in which they interact at the plasma membrane
level differs somewhat.
of

~

Similarly, the greater resistance

albicans to macrophage killing relative to other

species has been suggested to result from the less favorable stimulation of the respiratory burst enzyme in the
plasma membrane by

~

albicans (118).

Since pre-incubation of PEC-0 with SM-1213 enhances
the subsequent stimulation of PEC-0 oxidative metabolism
upon the addition of either zymosan or Candida (Figures 5,
6,7), its actions may involve:

1) interacting with or

alteration of the plasma membrane or the membrane oxidase;
2) changing the configuration of the stimulating agent;
3) changing the configuration of opsonins or the response
of PEC-0 to opsonins; or 4) enhancing the binding of stimulating agents to the membrane.

SM-1213 may enhance the

binding of Candida to the membrane oxidase in a manner
similar to that proposed by Wright !! al (130) for the
binding of MPO to Candida.

It was suggested (130) that the

binding of MPO to Candida was facilitated by electrostatic
forces, since MPO is a cationic enzyme and the surface of
Candida is anionic.

Similarly, the alkylaminoalkyl sub-

stitution of SM-1213 is cationic at physiological pH (P.
Gordon, personal communication) and may serve to bind SM1213 to candidal surfaces.

Drug treatment may thereby

change the surface of Candida so that the manner in which

101
fungi are presented to PEC-0 or are bound by PEC-0 is
altered.

Experiments conducted on the NADPH-dependent

production of 02 by cell lysates revealed that, in the
absence of Candida, SM-1213 could enhance NADPH-dependent
02 production (Figures 8 and 9, Table IV).

Therefore,

although candidal binding, candidal configuration, or
opsonic configuration may be influenced by drug, the activity of the NAD(P)H oxidase enzyme or the membrane in which
it is located is altered by SM-1213 treatment as well.
However, opsonins would probably not be affected, since
the enhanced killing of Candida by drug-treated PEC-0
occurred in their absence (Table II).
The NADPH-NAD(P)H oxidase system of PEC-0 was
directly modified by SM-1213 treatment (Table IV).

Super-

oxide anion production by cell lysates was enhanced an
average of 28.7% in the presence of drug, and this enhancement was increased to 50.2% if PEC-0 were pre-incubated
with drug prior to cell lysis (Table IV).
Drug-enhanced NADPH-dependent 02 production by cell
lysates was time dependent (Figures 8 and 9) and was not
apparent until the 6 h time interval.

This was the case

whether PEC-0 were pre-incubated with drug prior to lysis
(Figures 8 and 9) or pre-incubated without drug and exposed
to SM-1213 during the time of NBT assay only (Table IV) •
Therefore, PEC-0 become more receptive to drug modification
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with time in culture.

Indeed, unlike 02 production by

whole PEC-0, 02 production by cell lysates was enhanced at
6 h relative to at earlier time intervals (Figure 9}.

The

reduced activity at 0 h may have resulted from the presence
of contaminating red blood cells which contain SOD (75}.
Pre-incubation of PEC-0 with drug prior to cell lysis increased 02 production by cell lysates an average of 22.7%
relative to cell lysates treated with drug during NBT assay
only.

Thus, pre-treatment of PEC-0 with drug, as well as

incubation of PEC-0 in culture, primes phagocytes to produce greater quantities of 02.
The significantly

~igher

quantities of 02 produced

by cell lysates (Figure 9} relative to whole PEC-0 (Figure
6} may relate to the availability of the 02-producing
enzyme to activation.

Although located in the plasma mem-

brane (8}, NAD(P}H oxidase, once liberated by cell lysis,
may have more access to activation by substrate.

Also, the

exogenous addition of substrate in excess may allow for a
more complete expression of enzyme activity.

Others have

reported (SO} an increased production of 02 by cell lysates
relative to intact phagocytes, particularly in phagocytes
from patients with CGD.

Intact CGD phagocytes were marked-

ly deficient in 02 production, while cell lysates from CGD
phagocytes were only mildly deficient (50}.

It was sug-

gested that the enzyme or enzymes controlling 02 production
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were present within

CGD phagocytes, but that they were not

strategically placedl or not fully activated upon stimulqtion with a

phagocy~ic

particle (50).

NADPH-dependlent 02 production by cell lysates from
resident PEC was
V).

Also, the

no~

affected by SM-1213 treatment (Table

quan~ities

were generally lower
IV and V) •
dent and

of 02 produced by PEC-r lysates

than for PEC-0 lysates (Figure 9, Table

The basi_ s for these differences between resi-

oil-elicite~d

cell lysates may relate to the char-

acter of each of the:Se cell types.

The resident cells of

the peritoneal cavit_y, which are primarily mature macrophages, have been sh own by bthers (6) to differ from newly
recruited inflammato•rY cell types, which are primarily
monocytes.

The matu ration of mononuclear phagocytes into

macrophages is assoc iated with alterations of plasma membrane proteins, ecto-enzyme activity, and surface receptor
expression (17,18).

Although not readily apparent in our

studies, differences

in cell size (18) may also account for

differences in the reelative 02-producing capacities of
PEC-r and PEC-0.

Th•erefore, as mentioned earlier in refer-

ence to the modulati•On of PEC catalase activity, the physiological state and tihe state of differentiation of PEC can
influence phagocyte :functions and, in this instance, the
02-producing capacit=Y of PEC and the modulation of this
capacity by SM-1213.
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The significant relationship between the drugenhanced production of PEC-0 reactive oxygen metabolites
and the increased killing of Candida by drug-treated phagocytes was demonstrated upon incubation of Candida with an
NADPH-cell homogenate derived NAD(P)H oxidase system (Figure 12).

SM-1213 enhanced the candidacidal capacity of

this enzyme system.

The mechanism for this enhancement is

not known, but data from experiments previously discussed
using cell lysates (Figure 9, Table IV) suggest that SM1213 can directly enhance the Oz-producing capacity of
phagocyte NAD(P)H oxidase.

Experiments are underway to

determine if SM-1213 can also enhance the binding of Candida to NAD(P)H oxidase, and thereby enhance candidal
killing upon addition of NADPH.

Since 50-88% of candidal

killing by this system was inhibitable by SOD, the reactive
oxygen intermediate responsible for candidacidal activity
was most probably

Oz.

However, not all killing was due to

oxidative mechanisms, since some killing occurred in the
absence of substrate NADPH and when cell homogenates were
boiled prior to addition to the system (Figure 12).

Since

cell homogenates were utilized and not purified enzymes,
killing resulting from exposure of Candida to homogenates
may be due in part to non-oxidative candidal killing by
components derived from phagocyte lysosomal compartments
(i.e., cationic proteins) or other toxic agents, and is
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therefore an artifact of this system.

NADPH-dependent

killing is presumed to represent oxidative cytocidal mechanisms.

Therefore, an examination of the NADPH-independent

and NADPH-dependent killing of Candida revealed that the
majority of candidal killing by control cell homogenates
was NADPH-independent (non-oxidative) , while the greater
portion of candidal killing by drug-treated cell homogenates was NADPH-dependent (oxidative)

(Figure 12).

In whole

PEC-0, however, the proportion of oxidative to non-oxidative candidal killing may be much greater since, in cell
homogenates, a bolus of non-oxidative hydrolytic and degradative enzymes, as wellias candidacidal cationic proteins (66), may be released upon phagocyte lysis.
In conclusion, SM-1213 treatment of PEC-0 was
observed to inhibit the growth and reduce the viability of
intracellular Candida cells, as well as to enhance the
production of PEC-0 oxidative metabolites, hydrogen peroxide and superoxide anion.

The enhanced NADPH-dependent 02

production by phagocytes treated with SM-1213 and by cell
lysates treated with SM-1213 at the time of assay indicate
that the observed enhanced production of oxidative metabolites results from an increased activation of PEC-0 NAD(P)H
oxidase, the enzyme responsible for the production of
reactive oxygen species by phagocytes (8,91).

The role of

oxygen metabolites in the candidacidal activity of phage-
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cytes has been established by others (62,118), and the
modulation of NAD(P)H oxidase activity by SM-1213, resulting in a concomitant increased production of these agents,
was supported by the enhanced candidacidal action of the
NADPH-NAD(P)H oxidase system in the presence of SM-1213.

SUMMARY
SM-1213 [1,2-0-isopropylidene-3-0-3'-(N' ,N'-dimethylarnino-n-propyl)-D-glucofuranose] is a synthetic, substituted monosaccharide which exerts immunomodulatory actions.
In the absence of PEC, SM-1213 had no direct fungistatic or
fungicidal effect against the yeast or hypha! form of
Candida albicans, a clinically important opportunistic
fungus.

However, SM-1213 was effective in inducing PEC-0

to inhibit the intracellular formation and elongation of

c.

albicans hyphae and to reduce the percentage of viable

Candida remaining after phagocytosis.

Significant drug-

induced candidastatic and candidacidal effects were also
observed when PEC-0 were pre-incubated in the presence of
SM-1213 and washed prior to infection with Candida.

These

results indicate that SM-1213 was able to potentiate one or
more candidacidal processes expressed by PEC-0.

Pre-incu-

bation of PEC-0 with SM-1213 prior to introduction of a
phagocytic stimulus resulted in an enhanced production of
both hydrogen peroxide and superoxide anion.

In addition,

incubation of PEC-0 with SM-1213 for 6 h resulted in a
selective reduction in adherent cell catalase activity
relative to control PEC-0.

NADPH-dependent production of

superoxide anion was enhanced in cell lysates from PEC-0
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pre-incubated in the presence of SM-1213, as well as in
cell lysates from PEC-0 pre-incubated in the absence of
drug and exposed to SM-1213 during the time of assay.
NADPH-dependent killing of

~

was also increased by SM-1213.

albicans by PEC-0 homogenates
These data suggest that the

observed increased candidacidal effects for drug-treated
PEC-0 result in part from an enhancement of the NADPHdependent oxidative killing mechanisms of phagocytes and,
more specifically, from drug enhancement of phagocyte
NAD(P)H oxidase activity by mechanisms yet to be determined.
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